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Due to their capacity for self-renew and differentiation, pluripotent stem cells 
(PSCs) are used as a cell source in applications including tissue engineering, regenerative 
medicine, and studies of human development and disease. A common format for PSC 
differentiation is as three-dimensional (3D) cell aggregates. Differentiation of PSCs as 
aggregates mimics biochemical and biophysical aspects of in vivo embryonic 
development that promote differentiation and complex cell behaviors. Aggregates are 
used as a format both in directed differentiation approaches and in generating complex 
human tissue models such as organoids. Key challenges in generating and studying PSC 
aggregates include the low throughput and time-consuming nature of culture techniques, 
the lack of precise control over the culture microenvironment, and the inability to 
perform a variety of in situ functional assays. This thesis focuses on addressing some of 
these challenges through the development of microfluidics-based technologies for culture 
and assessment of stem cell aggregates.  
In Chapter 2 of this thesis, I developed a microfluidic platform for longitudinal 
monitoring and multi-modal phenotypic analysis of individual stem cell aggregates. This 
platform uses a hydrodynamic loading principle to capture pre-formed aggregates in 
independent traps, which enables physical isolation and tracking of aggregates during 
culture. I demonstrated that culture of aggregates in individual traps reduces 
heterogeneity in parameters such as size and gross morphology. Additionally, culture and 




the same platform, enabling correlation of multiple modes of analysis for individual 
samples.  
In Chapter 3 of this thesis, I applied the microfluidic platform developed in 
Chapter 2 in exploring how microfluidic culture parameters influence stem cell behavior 
and differentiation in the context of motor neuron differentiation. Transport modeling and 
experimental studies were used to assess how media exchange frequency and 
asymmetrical device geometries modulated the biochemical environment and 
differentiation. These studies demonstrated that discontinuous media perfusion was 
effective at supporting PSC aggregate growth, but there was a balance between sufficient 
media exchange frequency and allowing accumulation of required cell-secreted. Finally, 
work in this chapter showed how asymmetrical microscale geometries can be used to 
generate gradients of cell-secreted factors and induce asymmetric differentiation events. 
In Chapter 4 of this thesis, I developed a culture platform for brain organoids. 
This aim built upon technologies presented in the first two aims and extended these for 
much larger organoid tissue models. The platform developed in this aim allows culture of 
individual organoids in an array of chambers with controlled delivery of media and 
reagents, the ability to perform imaging-based assays, and the ability to retrieve 
organoids for end-point based assays. I developed and validated two iterations of the 
platform design. With each design, computational fluid dynamics and qualitative 
transport modeling were used to validate design choices and optimize culture conditions. 
I validated culture of forebrain organoids in the platforms for up to 42 days through 
characterization of organoid size, morphology, cell types, and structural features. Results 




developed comparably to conventional methods. Together, the work performed in this 
thesis establishes a set of technologies for higher throughput, robust formation of stem 
cell derived tissues of multiple size scales, coupled with highly informative assays. These 
tools provide new capabilities that can be broadly applied by other researchers in studies 












The chapter provides an introduction to three-dimensional pluripotent stem cell 
tissues, their applications, and challenges with current culture and analysis techniques. 
Portions of this chapter are adapted from the following two publications: ―Three-
dimensional models for studying development and disease: moving on from organisms to 
organs-on-a-chip and organoids‖ published in Integrative Biology in 2016
1
 and ―A 
microfluidic trap array for longitudinal and multi-modal phenotypic analysis of individual 
stem cell aggregates‖ published in Lab on a Chip in 2017
2
. 
1.1 Pluripotent Stem Cell Aggregate Differentiation 
1.1.1 Overview 
 
Pluripotent stem cells (PSCs) are uniquely able to self-renew and to differentiate 
into cells from each of the three germ lineages as well as germ cells. Due to these 
capabilities, PSCs have been widely studied for applications in understanding human 
developmental biology and developing tissue engineering strategies. Types of PSCs 
include embryonic stem cells (ESCs), which are derived from the inner cell mass of an 
embryo
3-5
, and induced pluripotent stem cells (iPSCs), which are created through 
reprogramming of somatic cells. The ability to generate iPSCs was first reported in 2006 
by Yamanaka
6,7
 and then independently by others
8-10
. iPSCs are similar to ESCs in terms 
of developmental potential and self-renewal but with additional advantages, including the 
relative ease of generating cell lines, the ability to generate patient- and disease-specific 
cells, and the avoidance of ethical issues associated with the source of ESCs. For these 
reasons, iPSCs have generated much excitement for use in disease modeling, drug 




One common format for differentiation of PSCs is as three-dimensional (3D) 
aggregates. In this format, many of the biochemical and biophysical interactions that 
occur during in vivo early embryonic development are mimicked
11,12
. In some contexts, 
PSC aggregates are referred to as ―embryoid bodies‖ (EBs), a term that describes 
spontaneous differentiation to cell types from each of the three germ lineages. EB 
differentiation has applications in modeling embryonic development and tissue 
morphogenesis. In addition to applications in studying embryonic development, PSC 
aggregates are frequently used as a step in directed differentiation protocols, including 
cardiac
13
 and neural differentiation
14
, as they promote cell-cell signaling and other 
interactions that facilitate differentiation. A variety of strategies have been developed for 
directing differentiation of aggregates, and examples of these include control of aggregate 
size
15-20





. Despite the development of many strategies for 
directed differentiation of PSCs in an aggregate format, there are still challenges in 
controlling differentiation and an incomplete understanding of the mechanisms that 
regulate differentiation. This thesis does not directly focus on these challenges, but rather 
on developing technologies that provide new capabilities for culture and phenotypic 
assesses of PSC aggregates. These technologies can then enable studies to improve 
understanding of stem cell differentiation. In the next section, an overview of current 
culture methods and their challenges is provided. 
1.1.2 Conventional Culture Methods and Challenges 
 
A variety of methods have been developed for formation and culture of PSC 




does not focus on methods for aggregate formation specifically, they are briefly described 
here to provide context. Aggregate formation methods include the spontaneous 
aggregation of cells seeded in low attachment tissue culture plates
5
 or hanging drops
27
 





. When aggregates are formed individually in hanging drops, 96-well 
plates, and microwells, the initial aggregate size can be specified by adjusting the cell 
seeding density. The consistent aggregate size produced by these methods reduces 
heterogeneity in the starting population, and controlling aggregate size is important, as 
size has been shown to influence differentiation.
18-20,33
  
Following formation, aggregates can be cultured in different types of culture 
systems. In batch-based culture platforms, aggregates are grown in suspension in petri 
dishes or larger vessels such as bioreactors, either under static
5
 or stirred 
conditions
13,16,17,34
. In static suspension culture, gradients of nutrients, metabolites, and 
soluble signaling molecules can form in the local environments of individual aggregates. 
In contrast, stirred suspension culture promotes more uniform spatial concentrations of 
soluble factors through mixing. The primary advantage of batch-based culture methods is 
the ability to culture many aggregates at once (up to 1,000s per culture vessel). However, 
one disadvantage is that aggregates can physically interact with one another in a 
stochastic manner, for example, when multiple aggregates agglomerate. These 
interactions can contribute to heterogeneity in the cultures. A second key disadvantage is 
the inability to observe and track individual aggregates throughout culture. Collecting 




for example, how differentiation processes evolve and how different phenotypic metrics 
correlate with one another.  
The second category of conventional aggregate culture systems is comprised of 
culture platforms that maintain individual aggregates in physically separate 




, and hanging 
drops
27
. Each of these culture systems enables manipulation and observation of individual 
aggregates, capabilities which batch culture methods do not provide. However, these 
systems can require time- and labor-intensive culture procedures that involve 
manipulation of individual aggregates and individual volumes of media. A second 
disadvantage is that high-resolution imaging is difficult to perform in situ for observing 
cell and aggregate phenotypes: the curved material comprising the bottom of a multiwell 
plate or microwell required for aggregate formation typically does not have a thickness, 
index of refraction, or shape suitable for confocal imaging. For hanging drop culture, 
imaging in situ at high magnification requires water immersion objectives which 
introduce risk of contamination into ongoing cultures. Finally, performing end point 
based phenotypic assays, such as immunostaining, in the same platform as used for 
culture can save time and labor and enable correlation of live and end point phenotypes. 
However, the many liquid handling steps required for immunostaining are tedious and 
use large volumes of reagents when performed in microwells, multiwell plates, or 
hanging drops.  
 Overall, the disadvantages associated with current PSC aggregate culture systems 
demonstrate the need for new culture technologies. Ideally, new culture platforms would 




required manual manipulation, longitudinal tracking of samples, and the ability to 
perform live- and end-point imaging-based phenotypic assays. This thesis will address 
these technological needs through the development of microfluidics-based culture 
systems for handling, culture, and performing imaging-based assessments of PSC 
aggregate differentiation. 
1.1.3 Motor Neuron Differentiation 
 
In order to demonstrate the capabilities of the microfluidic technologies 
developed in Chapters 2 and 3 of this thesis, they were applied to studying differentiation 
of mouse embryonic stem cells (mESCs) to spinal motor neurons (MNs). Differentiation 
protocols for generating MNs from ESCs and iPSCs are relatively well-established in 
literature, and MNs are a cell type that can potentially be used in therapeutic applications. 
These two considerations motivated using a MN differentiation protocol as an example 
application of our microfluidic technologies. To provide background and context for the 
biological studies performed in Chapter 3, a brief overview of MN differentiation is 
provided here. 
Previous work has investigated how MNs are generated during embryonic 





. For differentiation, PSCs are first formed into EBs and 
then exposed to the caudalizing signal retinoic acid (RA) to yield spinal progenitors. 
Next, upon exposure to the ventralizing signal Sonic hedgehog (Shh), spinal progenitors 
differentiate into progenitor motor neurons (pMNs). pMNs are characterized by the 
expression of the basic helix-loop-helix transcription factor Olig2
39,40
. Committed MNs 




homeodomain transcription factor Hb9
39,40
. In addition to committed MNs, pMNs also 
give rise to oligodendrocytes and astrocytes
41,42
. Previous studies have focused on 
understanding the signaling events that regulate these fate transitions and developing 
methods to generate MNs with higher efficiency and purity
43-45
. Together, previous work 
has contributed to an overall understanding of how MNs can be generated from PSCs. In 
Chapter 3, this differentiation pathway is applied in exploring how microfluidic culture 
parameters influence cell behavior and differentiation. 
 
1.2 PSC-Derived Organoids for Modeling Human Tissues  
1.2.1 Overview 
 
Recent work has shown the ability to generate organoids, which are 3D tissues 
derived from PSCs that mimic key tissue- and organ-specific features of cellular 
assembly, integration, and organization. Strategies for generating organoids rely on the 
self-organizing capabilities of PSCs, as opposed to traditional directed differentiation 
approaches
46,47
. More specifically, strategies for promoting self-organization aim to 
exploit and facilitate endogenously produced developmental signals to promote 
differentiation and morphogenesis of tissues. In contrast, directed differentiation methods 
often focus on using exogenous compounds to sequentially activate and inhibit key 
signaling pathways in a population of cells. To date, organoids have been developed for a 











Protocols for generating organoids share commonalities across different tissue types. 
They typically begin with the formation of an EB, followed by culture in different media 
formulations to facilitate self-organization, differentiation, and morphogenesis processes 




Matrigel, an extracellular matrix (ECM) based hydrogel extracted from the Engelbreth-
Holm-Swarm mouse sarcoma. Although the role of Matrigel is not completely 
understood, Matrigel seems to provide structural support and cell-ECM interactions that 
facilitate organoid development.  
One of the exciting applications of organoid cultures is for modeling human 
development and disease
53,54
. Organoids can potentially address gaps in knowledge in 
understanding diseases that are difficult or impossible to study using animal models—for 
example, because of significant physiological or behavioral differences. A key advantage 
is the ability to generate organoids from disease- and patient-specific iPSCs. Overall, 
organoids provide an exciting technology for studying development and disease in 
complex, human-specific tissue models. This thesis focuses on the development of new 
tools for culture and assessments of organoids. The goal is to provide new methods for 
studying organoids, thus enabling broader use of organoids in fundamental biological 
studies and in drug development. 
 1.2.2 Current Organoid Technology and Challenges 
 
A number of current challenges associated with producing organoids stem from 
the complexity of the biological processes involved in organogenesis. For self-
organization of cells into functional tissues to occur, a complex orchestration of events 
such as cell differentiation, cell migration, timed activation of signaling pathways, and 
formation of tissue architecture is required. As a result, in vitro organoid cultures are 
often highly heterogeneous. Furthering our understanding of the cues involved in self-
organization of tissues during in vivo development can aid in improving methods for 




generate organoids, there is a need for improved technologies for culturing organoids and 
characterizing organoid phenotypes. Existing culture procedures require time-consuming 
manual manipulation steps, such as embedding of individual organoids in Matrigel
55
 and 
mechanical removal of Matrigel at later time points during culture. In addition, the 
culture platforms that are typically used for organoids have a number of disadvantages. 
Organoids are typically cultured in platforms such as spinning bioreactors
52
, tissue 
culture plates, miniaturized spinning bioreactors
56
, and multiwell plates. Large 
bioreactors require large volumes of costly media and take up significant space; these 
issues make it difficult to multiplex experimental conditions. Tissue culture plates and 
multiwell plates use smaller media volumes and allow some multiplexing, but not to the 
extent required for large-scale screening. Disadvantages of these current systems 
highlight the need for new, miniaturized, culture technologies for use with organoids. In 
addition, the integration of imaging-based analysis tools with culture technologies will 
provide new abilities for characterization of live and intact organoid tissues. If methods 
such as live imaging, tissue clearing
57-60
, and immunocytochemistry can be performed in 
culture platforms, this will better facilitate screening. In this thesis, to address challenges 
associated with current organoid technologies, a miniaturized platform for organoid 
culture and screening was developed. This technology provides new capabilities for 
culture of individual organoids, imaging-based assessments, and screening, and it will 
enable future work in understanding how to generate organoids more reproducibly.  
1.2.3 Brain Organoids 
 
The technology developed in Chapter 4 for culture and assessments of organoids 




by the existence of a close collaboration with Dr. Zhexing Wen at Emory University, 
whose lab works extensively with this region-specific brain organoid type. Here, an 
overview of brain organoid technology and its applications is described in order to 
provide context. 
Brain organoids have exciting potential for studying human brain development 
and disease, as the human brain is particularly difficult to study. Studies of human brain 
development and disease have conventionally used medical imaging, post-mortem human 
brain samples, animal models, and in vitro two-dimensional (2D) cell cultures. Animal 
models, in particular, have yielded many important insights about brain development. 
However, many diseases are difficult to recapitulate in animal models, and the lack of 
human-specific physiology has limited translation of findings from animal models to the 
development of therapeutics
61





 organoids. Brain organoids, also referred to as cerebral 
organoids, typically contain tissues characteristic of multiple regions of the brain, 
whereas brain region-specific organoids model only one region of the brain. Brain 
organoids have been used to study human brain development
62,64,65
, differences in brain 
development across species
66
, autism spectrum disorders
67






An early application of brain organoid technology was the use of cerebral 
organoids generated from patient-derived iPSCs to model microcephaly
52
. Although 
mutations in several genes have been implicated in this neurodevelopmental disorder, 
mouse mutants do not exhibit the same severe reduction in brain size that is seen in 




differentiation, suggesting this as a potential cause for the disease phenotype. This also 
demonstrated the feasibility of using cerebral organoid cultures for studying human 
neurodevelopment and disease. In a second example of brain organoid technology, Qian 
et al.
56
 developed methods for generating region-specific organoids including forebrain, 
midbrain, and hindbrain. A key aspect of their method was the development of the SpinΩ 
bioreactor, a miniaturized spinning bioreactor in a 12-well tissue culture plate. The brain 
region-specific organoids and bioreactor technology were applied in studying 
mechanisms by which Zika virus infects brain tissue and produces phenotypes associated 
with microcephaly. These two brief examples illustrate how brain organoid models have 
enabled new studies of human development and disease. Overall, brain organoids show 
great promise in enabling new studies of the human brain and development of 
therapeutics. However, studies are still limited by challenges associated with culturing, 
handling, and reproducibly generating brain organoids. This thesis focuses on 
development of technologies that provide new abilities for culturing and handling brain 
organoids. These tools will broadly enable future studies focused on generating brain 
organoids more robustly and applying them in large-scale studies. 
 
1.3 Microfluidic Approaches for Studying PSC Aggregates 
 
Advances in microscale technologies have greatly facilitated the development of 
3D cell culture systems. With fabrication techniques borrowed from the microelectronics 
industry, as well as newer technologies such as 3D printing, microfluidic devices can be 
rapidly designed and prototyped.
68-71
 In a common method of fabrication known as soft 
lithography, a master mold is first made in a cleanroom, using photolithography to 




material such as polydimethylsiloxane (PDMS)
69
 and are bonded to a glass slide to create 
enclosed channels. PDMS is commonly used for biological samples because it is 
biocompatible and optically transparent, facilitating imaging. The inherent features of 
microfluidics, including the small size scale that matches biological samples and the 
existence of low Reynolds number, laminar flow, enable enhanced control over soluble 
and physical aspects of cellular microenvironments. Additionally, microfluidics can 
increase experimental throughput via assay integration, parallelization, and automation. 
Together, these capabilities make microfluidics well-suited for engineering 3D culture 
systems. 
1.3.1 Microfluidic Culture Methods for PSC Aggregates 
 
A number of microfluidic approaches have been developed to address 
technological challenges associated with formation, manipulation, culture, and analysis of 
cell aggregates. Microfluidic methods for forming aggregates of defined size include 









microscale technologies have been developed for culturing pre-formed aggregates in 
devices with wells or traps
83-87
.  In these methods, device features are used to individually 
position cell aggregates, thereby preventing physical interactions among aggregates and 
enabling tracking at multiple time points during culture. Device designs that allow in situ 
imaging enable acquisition of phenotypic information to be collected during and 
following culture. Some methods have also been developed for manipulation and 
perturbation of individual aggregates, such as controlled pairing of aggregates
88
. A 
significant disadvantage of current microfluidic technologies is that platform designs are 




Additionally, many trapping mechanisms physically constrain the aggregates, which can 
impart mechanical cues as the aggregates grow and increase in size during culture. Thus, 
there is still a need for microfluidic technologies that enable the culture of many 
individual PSC aggregates in controlled environments with the ability to perform 
longitudinal tracking and in situ imaging. This technological need will be addressed in 
Chapters 2 and 3 of this thesis. 
1.3.2 Microfluidic Culture Methods for Organoids 
 
Although many microscale technologies have been developed for handling cell 
aggregates, they have been relatively unexplored for the culture of organoids. One of the 
most significant challenges is handling organoid size changes. For example, brain 
organoids are a few hundred microns in size after formation but grow to a few 
millimeters in size after weeks to months in culture. Organoid growth, therefore, requires 
device features that range from the micro- to the meso-scale. In general, there are 
multiple ways in which miniaturized fluidic technologies can address the current 
challenges associated with organoid culture. Scaling down culture systems uses reduced 
media volumes and enables the multiplexing of conditions, making large-scale screens 
feasible. Fluidic flow can be leveraged to control spatial and temporal delivery of soluble 
molecules to define instructive cues that promote self-organization. Additionally, 
imaging-based assays can be performed in situ to facilitate live tracking of 
organogenesis. There are two key examples of technologies that have been developed for 
the culture of brain organoids. In the first, an array of micropillars was used to form brain 
organoids from single cells. Organoids were then embedded in Matrigel in the micropillar 
array and cultured
89




embedded in Matrigel and two side channels were used to perfuse media and 
reagents
90,91
.  Although both technologies were able to generate and culture cerebral 
organoids in a microfluidic device, neither device configuration is adaptable for 
screening, in which exposing subsets of organoids to different drugs, molecules, etc. is 
desired. Development of a microscale technology that provides the ability to reproducibly 
culture and screen individual organoids in controllable environments will help enable the 
use of organoids in studying human development and disease and in drug screening.  
 1.3.3 Considerations in Microfluidic Culture  
 
The cell microenvironment is composed of biochemical factors such as nutrients 
and cell-secreted molecules, physical factors such as substrates for cell growth and fluid 
shear, and physicochemical factors such as oxygen, pH, and temperature. Microscale 
culture platforms can be designed to control these different aspects of the cell 







 variation of the soluble microenvironment, and 
for probing autocrine/paracrine signaling
98,99
.  
Specifically for controlling the soluble cell culture environment, there are a 
number of aspects that microfluidic techniques provide control over. First, the density of 
cells per volume of media is typically significantly increased in microscale culture. This 
provides the opportunity for concentrating biochemical factors such as cell-secreted 
molecules but also requires tuning of media exchange to provide sufficient nutrients and 
remove waste. Length scales and media perfusion rate can also be tuned to operate in 
diffusion or convection-dominated regimes for modulating aspects of the biochemical 




signaling play in cellular processes
100
. In designing a microfluidics-based cell culture 
system, these types of parameters need to be carefully considered in design and validation 
of the system. This topic will be discussed in greater detail in Chapter 3 of this thesis. 
 
1.4 Thesis Objectives and Significance 
 
As discussed, there are a number of technical challenges associated with current 
conventional and microfluidic platforms for culture and assessments of PSC aggregate 
cultures. The overall objective of this thesis was to develop microfluidics-based tools that 
enable culture of individual stem cell aggregates, provide spatiotemporal control over the 
culture environment, and enable in situ, imaging-based assessments of cell phenotypes. In 
Chapter 2, a microfluidic platform was developed for culture of small (< 500 μm) stem 
cell aggregates that provides the ability to isolate individual aggregates, track aggregates 
throughout culture and perform in situ imaging and immunocytochemical analysis. In 
Chapter 3, the same microfluidic platform was improved upon and used to investigate 
how key microfluidic culture parameters modulate differentiation of ESC aggregates to 
motor neurons. This work enhances understanding of how aspects of microfluidic culture 
influence cell growth and differentiation and informs design of future studies. Chapter 4 
presents a miniaturized platform for culture and imaging-based assessments of forebrain 
organoids. This work combined modeling and experimental approaches to validate 
culture of organoids in the platform, establishing the platform as tool that can be broadly 
applied in future organoid studies and screens. Finally, Chapter 5 of this thesis provides 






CHAPTER 2 : A MICROFLUIDIC PLATFORM FOR LONGITUDINAL 
MONITORING AND MULTI-MODAL PHENOTYPIC ANALYSIS OF 




This chapter is adapted from a research article entitled ―A microfluidic trap array 
for longitudinal and multi-modal phenotypic analysis of individual stem cell aggregates‖ 





Pluripotent stem cells (PSCs) have the ability to self-renew and differentiate to the 
three germ lineages.
3,4,101
 In particular, when PSCs are cultured as three-dimensional 
(3D) cellular aggregates, they mimic many of the biochemical and biophysical 
interactions that occur during in vivo early embryonic development.
11,12
 Efforts to direct 
stem cell aggregate morphogenesis have demonstrated that complex 3D tissue structures, 
termed ―organoids‖, can be generated in vitro,
46
 and that these tissues recapitulate many 
key features of native tissue structure and function.
48,52,102
 Thus, the generation of PSC-
derived tissue models has broad applications in studying mechanisms of tissue 
development, in disease modeling, and in drug screening. 
Within the 3D stem cell culture microenvironment, both exogenous and 
endogenous biophysical and biochemical cues mediate cellular differentiation and 
morphogenesis. Maintaining uniformity of aspects of the culture microenvironment is 
important for standardizing differentiation and morphogenesis of cultures. For example, 
changes in aggregate size can influence differentiation by affecting diffusive transport of 
oxygen, nutrients, and morphogens.
103
 In addition, modulating the frequency of media 






Despite development of various strategies to improve uniformity of cell aggregate 
cultures, for example by controlling aggregate size,
17,19,106
 a significant amount of 
heterogeneity often remains within cultures. It is unclear how factors such as biological 
stochasticity, environmental parameters, and experimental procedures each contribute to 
the heterogeneity, thus motivating the development of technologies that enhance the 
ability to standardize stem cell aggregate differentiation and morphogenesis by providing 
improved control of the 3D cellular microenvironment.  
A variety of culture systems have been developed for stem cell aggregates. One 





 suspension conditions in petri dishes or larger vessels. Batch-based 
methods enable high-throughput culture (1,000s per experiment) and have been shown to 
improve uniformity in aggregate size, such as in stirred suspension cultures.
17
 However, 
in batch systems, aggregates can physically interact with one another in a stochastic 
manner, which can contribute to heterogeneity in differentiation. An additional challenge 
associated with batch-based culture systems is the lack of ability to longitudinally 
observe and track individual samples throughout culture. Observation of differentiation 
and morphogenesis at multiple time points in the same samples is of interest, for 
example, in order to understand how processes evolve through time and to observe 
population heterogeneity. Culture platforms which physically isolate cell aggregates 







, and hanging drop
27
 culture. However, 
with each of these methods, it is labor- and time-intensive to manipulate aggregates 




require delivery of soluble factors with time scales on the order of seconds to hours are 
challenging. Additionally, high-resolution imaging, such as confocal microscopy, cannot 
be performed directly with these culture platforms for live and end-point imaging of 
sample phenotypes.  
In contrast to macroscale culture systems, microfluidic-based platforms offer the 
ability to address challenges related to culture and handling individual cellular 
aggregates. Microfluidic systems provide spatiotemporal control over the culture 
microenvironment due to the nature of low Reynolds number flow and the ability to 
precisely control media exchange rates.
108
 Additionally, microscale features can be 
designed to position and culture cellular aggregates within individual chambers. Finally, 
microfluidic devices made with traditional soft lithography techniques,
71
 fabricated from 
polydimethylsiloxane (PDMS), and bonded to glass coverslips are compatible with high 
resolution microscopy for live imaging-based assessment of aggregate differentiation.  
While previously a few microfluidic approaches for culturing cellular aggregates 
have been demonstrated, there are technical demands that these systems do not fully 









, followed by culture of the 
resulting aggregates. Forming aggregates within devices allows for control of initial size, 
as with many off-chip methods, and circumvents the challenge of transferring pre-formed 
aggregates into devices.  However, many of the methods that use microwells within 
microfluidics to form aggregates are not compatible with high-resolution imaging during 
culture, due to limitations of objective working distances through the device material. In 




samples during culture. Additionally, having the ability to perform off-chip aggregate 
formation and pre-treatment steps is desired in many protocols, which these existing 
platforms do not currently possess. Examples of the utilities of this capability include 
formation of aggregates from multiple cell types, incorporation of microparticles within 
aggregates, and Matrigel embedding steps. Thus, a platform that is designed for loading 
of pre-formed aggregates has greater experimental flexibility and can be used more 
broadly. While previous work has shown the ability to load pre-formed aggregates into 
devices with wells or traps,
83-87
 the majority of existing platforms are low-throughput, 
accommodating 20 samples or less, and are not inherently scalable (e.g. the fluidics 
required for trapping are not compact or the trapping mechanism is not deterministic). In 
addition, many existing platforms use trapping mechanisms that physically constrain 
aggregates, which in addition to limiting space for size increases during culture can also 
impose exogenous mechanical cues or induce diffusion limitations in traps.  
In this chapter, we have created a culture platform for stem cell aggregates that 
satisfies the following criteria: can be deterministically loaded with pre-formed 
aggregates, allows aggregate growth over multiple days of culture without physically 
constraining aggregates, is compatible with high resolution live and end point imaging, 
and has a compact design that can be scaled up to increase higher throughput. We show 
that this microfluidic platform provides the ability to culture and perform multi-
functional, on-chip phenotypic analyses of individual stem cell aggregates at high spatial 
density. This is facilitated by the abilities to deterministically trap individual pre-formed 
aggregates, easily exchange fluids, and couple devices directly with high-resolution 




size and morphology. We envision applications of this technology in standardizing the 
generation of PSC-derived tissue models and in expanding abilities for phenotypic 
analysis. 
2.2 Materials and Methods 
2.2.1 Device Fabrication 
 
Microfluidic devices were fabricated in polydimethylsiloxane (PDMS) (Dow 
Corning Sylgard 184, Midland, MI) by soft lithography.
71
 Briefly, a master mold was 
fabricated by standard UV photolithography with the negative photoresist SU8-2100 
(Microchem, Newton, MA) to create three layers of respective heights 200 μm, 100 μm, 
and 200 μm. Before PDMS molding, the master was treated with tridecafluoro-1,1,2,2-
tetrahydrooctyl-1-trichlorosilane vapor (United Chemical Technologies, Bristol, PA) to 
allow release of the PDMS. To make devices, PDMS was mixed in a 10:1 ratio of pre-
polymer and crosslinker, degassed to remove air bubbles, poured on the master mold, 
degassed a second time to remove remaining bubbles, and cured for 2 hours at 70 °C. 
Following curing, devices were cut and inlet and outlet holes for fluidic connections were 
punched with 18 gauge blunt needles (McMaster-Carr, Elmhurst, IL). Devices were then 
bonded onto glass coverslips by oxygen plasma bonding. 
2.2.2 Mouse Embryonic Stem Cell Culture 
 
Mouse ESCs (D3 cell line) were maintained in tissue culture-treated polystyrene 
dishes (Corning Inc., Corning, NY) coated with 0.1% gelatin (Millipore, EmbryoMax). 
Undifferentiated culture media consisted of Dulbecco’s modified Eagle’s medium 
(DMEM) (Mediatech, Herndon, VA) supplemented with 15% fetal bovine serum 




amphotericin (Mediatech), 2 mM L-glutamine (Mediatech), 1x MEM non-essential 
amino acid solution (Mediatech), 0.1 mM 2-betamercaptoethanol (Fisher Scientific, 
Fairlawn, NJ), and 10
3 
U/mL leukemia inhibitory factor (LIF) (ESGRO, Chemicon, 
Temecula, CA). Cells were passaged at approximately 70% confluence (typically every 
2-3 days) and seeded at a density of 1 million cells for a 100 mm plate. Culture media 
was completely exchanged every other day. 
2.2.3 Aggregate Formation and Culture 
 
A single cell suspension of undifferentiated mESCs was obtained by dissociating 
monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Aggregates were formed by 
centrifugation (200 rcf) of mESCs into 400 μm agarose (OmniPur®, EMD Millipore) 
microwells placed within a 6-well tissue culture polystyrene plate (Corning, Inc.).
106
 To 
yield either 500 cell or 1000 cell aggregates, volumes of 1 mL or 2 mL, respectively, of 
the single cell suspension (concentration: 3 million cells/mL) were added to each well of 
the 6-well plate.  Cells were incubated in the wells in culture media without LIF for 
approximately 18-24 hours to allow aggregates to form.  
For batch suspension culture, following formation aggregates were cultured in 
100 mm bacteriological grade polystyrene Petri dishes (BD, Franklin Lakes, NJ) with 
approximately 2000 aggregates per plate in 10 mL of culture media (without LIF). Plates 
were maintained on rotary orbital shakers (Benchmark Scientific, Edison, NJ) at a 
frequency of 45 rpm.
15,17
 Media was exchanged every other day, with 90% of the media 
replenished with fresh media. 
For multiwell culture, following formation aggregates were cultured in 96-well U-




(ThermoFisher) for 1 hour to prevent cell attachment to the surface.  To achieve one 
aggregate per well, aggregates were initially suspended in media without LIF at a 
concentration of 400 aggregates/mL and diluted twice (at 1:10 and 1:12.5) to yield a final 
concentration of 5 aggregates/mL before volumes of 200 µL were pipetted into each well. 
The final volume of each well was 200 µL, and no media exchange was performed for 
the duration of culture.  
2.2.4 Device Loading and Operation 
 
Prior to each experiment devices, fittings (blunt 16 gauge needles; McMaster-
Carr), and tubing (1/32‖ ID silicone tubing; Cole Parmer) were sterilized by autoclaving. 
Devices were connected to a second identical device during operation to increase the 
overall fluidic resistance and thereby decrease the flow rate during loading. Prior to 
aggregate loading, devices were first primed with 70% ethanol using a syringe to remove 
air bubbles. Next, devices were rinsed with sterile phosphate-buffered saline (PBS) and 
then incubated with a 1 mg/ml bovine serum albumin (BSA; Millipore) solution for 30 
minutes to passivate the surfaces.
73,109
 A 200 µL pipette tip filled with cell culture 
medium was placed at the device inlet for aggregate loading and perfusion. Aggregates 
were collected and resuspended at a concentration of approximately 600 aggregates/mL 
in a solution of 1.05 g/mL Percoll (Sigma Aldrich) in phosphate-buffered saline (PBS) to 
prevent rapid settling. Then, aggregates were pipetted into the inlet and loaded into 
devices via gravity-driven flow. Once aggregates were loaded, device outlets were 
connected to a syringe pump (PHD 2000; Harvard Apparatus), and the entire setup was 
placed in a humidified incubator (HERAcell 240i, Thermo Scientific). During culture, 




without LIF from a 200 µL pipette tip reservoir at the inlet. Additionally, devices were 
kept in a shallow, sterile water bath to limit evaporation. Phase contrast images of loaded 
devices were acquired using an EVOS microscope (LifeTechnologies).  
2.2.5 LIVE/DEAD Assay 
 
A LIVE/DEAD assay (Invitrogen) was performed to evaluate cell viability at day 
4 of differentiation. For aggregates cultured in devices, all steps were performed in 
devices. For aggregates cultured in batch suspension culture, all steps were performed in 
1.5 mL microcentrifuge tubes. Aggregates were rinsed with PBS and then incubated with 
2 µM calcein AM and 4 µM Ethidium-D in PBS with calcium and magnesium for 45 
minutes. Samples were imaged on a confocal microscope (Zeiss LSM 700 Confocal 
Microscope). Device samples were imaged in devices; batch suspension culture samples 
were transferred to glass-bottom 24-well plates (MatTek Corporation) for imaging. Z 
stacks were acquired up to a depth of approximately 50 µm with a spacing of 3 µm.  
2.2.6 Immunofluorescent Staining and Imaging 
 
Immunofluorescent staining was performed in devices by perfusing all solutions 
through the pipette tip inlets by gravity-driven flow. For aggregates cultured in batch 
suspension, all steps were performed in 1.5 mL microcentrifuge tubes, and samples were 
continuously rotated on a tube rotator. For multiwell culture, all steps were performed in 
multiwell plates. First, samples were washed with PBS and fixed in 10% formalin at 
room temperature for 40 minutes. Following a wash in block buffer (2% BSA, 0.1% 
Tween 20, in PBS), samples were permeabilized in 1.5% Triton X 100 in PBS for 30 
minutes. After washing in serum block buffer (2% donkey serum, 0.1% Tween 20, in 




primary antibody solution (1:200 Santa Cruz Biotechnology Oct-3/4 (N-19): sc-8628 in 
serum block buffer). The next day, samples were washed in serum block buffer for 30 
minutes and then incubated in the secondary antibody solution (1:200 AlexaFluor®546 
donkey anti-goat) at room temperature for 4 hours. For the final 15 minutes of incubation, 
nuclear stain Hoechst 3342 was added (final concentration: 10 µg/mL). Samples were 
washed a final time with serum block buffer for 30 minutes, stored overnight at 4⁰ C, and 
imaged the next day. Device samples were imaged in devices; batch suspension culture 
samples were transferred to glass-bottom 24-well plates (MatTek Corporation) for 
imaging. Samples were imaged on a confocal microscope (Zeiss LSM 700 Confocal 
Microscope) with a 20x objective. Z stacks were acquired up to a depth of 30 µm with 
spacings of 3-5 µm. For larger aggregates that did not fit in a single field of view, 2x2 tile 
scan images with 10% overlap were acquired and stitched together with the microscope 
software (ZEN, Zeiss). 
2.2.7 Fluorescent Image Analysis 
 
For each aggregate, a single two-channel z slice approximately 15 µm in from the 
surface was analyzed using custom-written MATLAB code. The two-channel image was 
separated into individual single-channel images, corresponding to the nuclear stain 
(Hoechst) and Oct4 antibody staining. As Oct4 is localized to the cell nucleus, we 
segmented nuclei in order to quantify Oct4 expression for each cell. To segment the 
nuclei, we used a modified version of a method developed by Lou, et al
110
. Starting from 
the greyscale nuclear stain image, contrast adjustment was performed as a preprocessing 
step. Next, we applied a Gaussian filter to the image, calculated the Hessian matrix of the 




threshold was applied to the first eigenvalue of the Hessian matrix to eliminate dim pixel 
values that would otherwise result in poor segmentation. The resulting image was used as 
a mask to segment the contrast adjusted greyscale nuclei image. This typically yielded 
slightly under-segmented nuclei, so a watershed transform was applied to the masked 
greyscale nuclei to yield a final, binary image of segmented nuclei. The image of 
segmented nuclei was then used to identify and segment nuclei in both the nuclear and 
Oct4 individual greyscale images.  
To quantify Oct4 expression for each cell, the mean Oct4 pixel intensity was 
calculated and normalized by the mean Hoechst pixel intensity for the same cell. This 
yielded a metric for cellular Oct4 expression (Ratio of Oct4/Hoechst). To obtain a metric 
for mean Oct4 expression for a single aggregate (Ratio of Oct4/Hoechst), the cellular 
metric was averaged for all cells in the aggregate.  
The coefficient of variation (CV) was used to describe the heterogeneity in Oct4 
expression among cells within a single aggregate or among aggregates within a culture 
platform. In the former case, the CV was defined as the standard deviation in cellular 
Oct4 expression for a given aggregate, divided by the mean value for all cells in that 
aggregate. In the latter case, the CV was defined as the standard deviation in aggregate 
Oct4 expression for all aggregates in a given culture platform, divided by the mean value 
for all aggregates.  
2.2.8 Aggregate Size and Growth Rate Analysis 
 
Aggregate sizes were quantified from phase contrast images. Images were 




measured. The aggregate radius was calculated from the cross sectional area, assuming 
each cross section to be circular and using the formula:  
         √
    
 
 
Growth rate was defined as change in radius between D1 and D4, normalized by the 
initial radius. This metric was calculated on a population-averaged basis, e.g.  
                     
                                           
                     
 
This was calculated on a population averaged basis due to the inability to measure the 
size of a single batch aggregate on both D1 and D4. 
2.2.9 Peclet Number Calculation 
 
We calculated the Peclet number (Pe) using the equation    
  
 
 where   is the 
characteristic length,   is the fluid velocity, and   is the diffusion coefficient. We 
assumed   to be the width of the main channel (300 µm). We calculated   ~ 30 µm/s 
using the relationship     
 
 
 where   is the volumetric flow rate through the device (10 
µL/hr) and A is the cross-sectional area of the main channel ((300 µm)
2





/s for a small molecule.
111
 Using these values yielded Pe ~ 90.  
2.2.10 Statistical Analysis 
 
Experiments with replicate data are represented as the mean +/- standard 
deviation. Sample sizes (n) and number of independent experiments are detailed in the 
corresponding figure legends. Statistical analyses were performed using GraphPad Prism 
software. Statistical tests were performed using either a Mann-Whitney U test or non-




comparison’s test for comparison of individual samples. P values less than 0.05 were 
considered significant.  
2.3 Results and Discussion 
2.3.1 Design of the Microfluidic Device 
 
The design of the microfluidic device consists of an array of 105 traps for culture 
of individual aggregates (Figure 2.1). Although the master is a multi-layer master, the 
devices can be fabricated using a standard single-layer PDMS micromolding process. The 
traps are connected by a main channel for aggregate loading and perfusion of media and 
reagents. Loading of individual aggregates into traps is accomplished by a previously 
demonstrated hydrodynamic loading mechanism
112-114
 that is dependent on the ratio of 
two flow paths in the device (Figure 2.1e). Briefly, the presence of a resistance channel 
at the back of each trap creates a secondary flow path that directs aggregates into traps. 
Once an aggregate enters a trap it blocks most of the flow to that trap so that subsequent 
aggregates preferentially continue to flow down the main channel and enter subsequent 
traps. Isolating individual aggregates in separate traps has a number of advantages, 
namely, preventing physical interactions between aggregates and enabling longitudinal 





Figure 2.1. Overview of microfluidic platform. a) Schematics illustrate the design of the 
device, with inset detailing the main channel, trap, and resistance channel.  b,c) Diagrams 
show key device geometrical features. d) Photograph of a dye-filled device. e) Image 
shows the hydrodynamic loading mechanism, which is dependent on the balance of flow 
through the main channel versus flow through the traps and resistance channels. 
 
Designing a device that allows for both initial loading of aggregates and 
subsequent culture of aggregates with significant size changes presents an engineering 
challenge. For reproducible loading of single aggregates in individual traps, there are two 
primary design requirements. First, the dimensions of the resistance channels must be 
small enough such that aggregates are not able to pass through the resistance channels 
during loading. To address this, we designed the resistance channel width (60 µm, Figure 
2.1b) to be less than half of the average diameter (~160 µm) of aggregates used for this 
study. Second, the relative fluidic resistances of the two flow paths in the device must be 
properly balanced for efficient loading of traps.
112,113
 If flow through the traps and 
resistance channels is too low (fluidic resistance is too high), then few aggregates will be 




traps, also resulting in inefficient trapping. These requirements were balanced in the final 
device dimensions (Figure 2.1b,c). We found that a ratio of trap to main channel 
resistance of ~20 resulted in good loading. To address the challenge of designing a device 
that physically accommodates growing aggregates over multiple days of culture, a 
pinched-off circular trap geometry was used (Figure 2.1b,c). The trap dimensions (500 
µm width and height) allow for initial loading of relatively small aggregates (< 190 µm in 
diameter) without constricting growing aggregates over time (up to a maximum diameter 
of 500 µm).  
2.3.2 Device Operation and Validation 
 
To demonstrate the capabilities of our platform for aggregate culture, we 
differentiated aggregates by removing LIF from the culture media. Aggregates were pre-
formed in microwells (D0) and then loaded into devices the following day (D1) (Figure 
2.2a). For comparison, aggregates were also differentiated in batch suspension culture. 
When devices were loaded, typically ~50% of traps were loaded with single aggregates, 
with the remaining traps containing no or multiple aggregates. We observed that multiple 
aggregate loading often occurred when clumps of aggregates entered a trap together, or 
when the first aggregate to enter a trap did not block the restriction channel before a 
second aggregate entered. The loading efficiency of this device reflects the tradeoff of 
scaling the traps to be small to allow effective loading and scaling to be large so that they 
can allow the aggregate size changes of up to five-fold over the course of culture. This is 
a unique challenge, in contrast to examples of previous work that trap objects such as 
cells and embryos, which do not grow bigger during the course of experiment and thus 




constraining aggregates within traps means that the deterministic loading mechanism 
results in an unavoidable imperfect loading efficiency. To compensate for the 50% 
loading efficiency, one could simply scale up the number of traps to increase the number 
of successful samples, which is well within experimental control. A scaled-up device 
would occupy a larger footprint, but there are no inherent design or operational 
challenges inherent to scaling up the platform other than making larger masters.  
 
Figure 2.2. Validation of device culture. a) Experimental design. b) Phase contrast 
images show representative aggregates at days 1 and 4 of differentiation. c) 
Representative confocal images of day 4 aggregates treated with a LIVE/DEAD stain 
(live cells: green, dead cells: red); (i) Maximum projection images; (ii) single channel z 
planes.   
 
Aggregates remained trapped over multiple days of culture, as seen in the 
representative phase contrast images (Figure 2.2b). Importantly, aggregates maintained a 
three-dimensional, spherical morphology during device culture, comparable to that of 
batch suspension culture, as opposed to plating down on the glass surface and forming 




no cell adhesion to the glass culture surface, we observe that day 4 aggregates can move 
within the device under flow perturbations. Devices were continuously perfused at a flow 
rate of 10µL/hr, which was approximately equivalent to exchanging the volume of the 
device once per hour. This flow rate was chosen as it was comparable to the media 
exchange rate of batch suspension culture on the basis of volume of media per aggregate 
per time. To confirm that this perfusion rate supported cell viability aggregates were 
treated with a LIVE/DEAD stain. Representative confocal microscopy images (Figure 
2.2c; Appendix A.2) demonstrated that there was high viability and minimal cell death in 
aggregates cultured in devices for 4 days and that viability was comparable to that of 
batch culture.  
2.3.3 Growth and size control 
 
A disadvantage of batch-based aggregate culture methods is that samples can 
physically interact with one another, which introduces a source of heterogeneity into 
cultures. We hypothesized that culture of aggregates in individual traps would maintain 
better uniformity compared to batch suspension culture in aspects such as size and 
morphology by preventing physical interactions between multiple aggregates. To assess 
how device culture impacted aggregate morphology and size during differentiation, phase 
contrast images of aggregates were acquired at day 1 (immediately following loading) 
and day 4 of differentiation, and the batch and on-chip cultures were compared (Figure 
2.3a). In batch cultures at day 4, a variety of aggregate sizes and morphologies were 
observed. The presence of small aggregates in the cultures (comparable to day 1 sizes) 
was likely the result of single cells shedding off from aggregates and forming new, 




morphologies, i.e. aggregates with small, spherical protrusions, were also observed in 
batch cultures Figure 2.3a, indicated by white arrows). In contrast, aggregate sizes were 
more uniform and the budding morphology was observed less frequently in device 
cultures. 
 
Figure 2.3. Device culture reduces variability in aggregate size. a) Phase contrast images 
showing size and morphology at days 1 and 4. Red arrows indicate subpopulations of 
much smaller aggregates. White arrows indicate aggregates with budding morphologies. 
b) Aggregate radii were quantified from phase contrast images at day 1 (before loading 
into devices) and day 4 of differentiation.  Two independent samples are shown for each 
condition, with n ≥ 80 aggregates for batch and n ≥ 40 aggregates for devices. * P < 




Growth rate was defined as change in size between days 1 and 4, normalized by initial 
size.  n ≥ 2 batch samples or devices, respectively, per condition. All samples: n.s. 
 
 Aggregate size was quantified from the phase contrast images. At day 4, the mean 
size was similar for batch and device cultures, but there was a subpopulation of smaller 
aggregates present in the batch cultures, consistent with qualitative assessments (Figure 
2.3b). The size distribution of aggregates was significantly larger for batch culture 
compared to device culturing, demonstrating the utility of the microfluidic platform for 
controlling aggregate size. It was also observed that device culture better controlled 
aggregate size compared to batch for different initial sizes of aggregates (500 cell starting 
size) (Appendix A.3).  
 Previous work has shown that microfluidic perfusion culture can modulate the 
soluble microenvironment, thereby affecting cell phenotype.
100
 To characterize basic 
characteristics of the soluble environment, we calculated the Peclet number and found it 
to be ~90, suggesting that the platform operated under a convection-dominated regime. 
Based on the perfusion rate used, soluble molecules secreted by cells likely had a short 
enough residence time (~ minutes) to have a minimal effect on aggregates in neighboring 
traps. Additionally, it is possible that an aggregate’s position within a device (i.e. closer 
to the inlet versus outlet) could have an impact on its phenotype. From the size data, 
however, there was no evidence that aggregate phenotypes differed depending on 
position in the device (Appendix A.3c-e and A.5a-b). 
 We compared the growth rate of aggregates cultured in devices to those 
maintained in batch culture. The metric for growth rate was defined as the change in 
average radii between days 1 and 4 of culture, normalized by the initial radii. We found 




compared to batch, for two different starting sizes of aggregates (500 cell and 1000 cell) 
and at a device perfusion rate of 10 µL/hr (Figure 2.3c). From this, we conclude that at 
these parameters, aggregates receive sufficient nutrients and grow comparably. 
Interestingly, aggregates cultured at a perfusion rate of 5 µL/hr exhibited a noticeably 
lower growth rate than batch (although not statistically significant as a result of low 
sample numbers) (Figure 2.3c). Importantly, we did not observe significant differences 
in viability for this condition (Appendix A.2), suggesting that the reduced growth rate in 
devices could be due to limited mass transfer of nutrients. For this reason, the following 
experiments were conducted at 10 µL/hr perfusion. 
2.3.4 On-chip immunofluorescent staining and imaging analysis 
 
To demonstrate the utility of our microfluidic platform for performing various 
phenotypic assays on-chip in conjunction with multi-day culture, we fixed and 
immunofluorescently stained aggregates at day 4 of differentiation (Figure 2.4).  
 
Figure 2.4. On-chip immunostaining and quantification of protein expression. (1) 
Immunostaining is performed on-chip by perfusing all reagents through the device via 
gravity-driven flow. (2) Confocal microscopy is used to image samples. (3) Image 





We examined expression of the pluripotency marker Oct4, which is highly expressed in 
pluripotent stem cells and decreases in expression over the first week of undirected 
aggregate differentiation.
115
 Oct4 expression was quantified in day 4 aggregates cultured 
in devices, batch, or round bottom 96-well multiwell plates
116
 (Figure 2.5). We 
performed a multiwell culture condition in order to compare on-chip differentiation to a 
platform where aggregates are also physically isolated. We hypothesized that the 
differences we saw in size and morphology between aggregates cultured in devices 
versus batch may manifest in differences in Oct4 expression. However, similar 
expression levels were observed across the three conditions. Aggregates cultured in 
devices had slightly higher Oct4 expression levels than both batch and multiwell culture 
formats (Figure 2.5b, Appendix A.5e). Although aggregate size can play a role in 
phenotype and rate of differentiation,
18-20,33
 we did not find a correlation between Oct4 
expression and aggregate size (Appendix A.5a-c). This data suggests that microfluidic 
culture can be leveraged to modulate aggregate differentiation, in this case, by 
maintaining pluripotency of aggregates at a higher level following LIF removal from the 
media. Previous work has demonstrated that microfluidic perfusion modulates the 
residence time of soluble secreted factors in the cellular microenvironment,
99
 and this 
may play a role in promoting pluripotency, although the specific mechanism in this case 





Figure 2.5. Device facilitates studying individual sample phenotypes. a) Representative 
immunostaining images. b) Mean aggregate Oct4 expression for different culture 
platforms. Two independent experiments are shown for batch and device conditions (n ≥ 
25 each) and one experiment is shown for multiwell condition (n = 8). * P < 0.00001 vs. 
batch and P < 0.0001 vs. multiwell.  c) Inter-aggregate heterogeneity in Oct4 expression 
for device and batch cultures. 
 
Next, we calculated the coefficient of variation of Oct4 expression to examine 
inter- and intra-aggregate heterogeneity in expression levels, across a given culture 
platform (Figure 2.5c, Appendix A.5f). There were no significant differences in inter-
aggregate heterogeneity (Figure 2.5c), suggesting that each of the culture platforms 
perform equally well in this particular respect. However, there were subtle differences in 
intra-aggregate heterogeneity, indicating that there was more diversity in the Oct4 
expression levels among cells of a single aggregate in device samples. Although these 
studies focused on a limited number of parameters to assess cell phenotypes, we 
anticipate that future studies will be valuable to assess how microfluidic culture 








Here we present the development of a microfluidic platform for culture, 
longitudinal tracking, and imaging of stem cell aggregates. Physical isolation of 
individual aggregates in individual traps prevents aggregate-aggregate interactions that 
contribute to heterogeneity in cultures and also enables correlation of live imaging and 
end point assay phenotypic information. Culture of aggregates in a high-density array 
format permits culture and analysis of ~50 samples at once, and this platform can be 
readily scaled up or parallelized to increase throughput. Finally, the design of the device 
permits high-resolution imaging for assessment of sample phenotypes, including 
incorporating techniques such as tissue clearing and multiphoton microscopy to image 
through denser, larger tissue constructs. Due to these combined capabilities, we anticipate 
that this platform can be applied for the generation of stem cell derived microtissues for 
drug screening and mechanistic studies of stem cell differentiation and tissue 
morphogenesis. Future applications are not limited to stem cells, and this platform could 
readily be applied to studying other cell aggregate systems, such as tumor spheroids. 
With the combined advantages of standardizing the culture environment and enabling 
single sample level analysis, we envision this platform as a tool in generating PSC 






CHAPTER 3 : MODULATION OF MOTOR NEURON DIFFERENTIATION OF 




This chapter applies the microfluidic technology developed in Chapter 2, with the 
objective of exploring how microfluidic culture parameters influence stem cell aggregate 
behavior and differentiation. Experimental studies and transport modeling were used to 
assess how media exchange frequency and device geometries modulate the biochemical 
microenvironment, including availability of exogenous and cell-secreted molecules, and 
thereby impact differentiation. These studies were done in the context of differentiation 
of mESCs to progenitor motor neurons. 
 
3.1 Introduction 
Chapter 2 demonstrated a microfluidic device that provides the ability to culture, 
perturb, and observe individual stem cell aggregates
2
. This platform has wide 
applicability for studying mechanisms of stem cell differentiation, generating stem cell 
derived tissue models for drug screening, and developing methods for generating 
therapeutically relevant populations of cells. However, exploring any of these 
applications requires an understanding of how microfluidic culture conditions impact cell 
behavior and differentiation. Conventional cell culture techniques cannot directly be 
applied to the microscale, as microscale culture varies from macroscale culture in ways 
that can critically affect cell behavior.  
One key difference in microscale culture is that the density of cells per volume of 




careful consideration of the method and frequency with which media exchange is 
performed, so that there is sufficient delivery of nutrients and removal of waste. 
Approaches to considering media exchange in microfluidics have been discussed by 
Przybyla and Voldman
100




. One method of choosing a 
media exchange interval or rate is to match volumes typical of bulk culture conditions 
(e.g. ~50-500 pL/h/cell for ESCs)
100
. A second method is to consider reaction and 
diffusion time scales of nutrient consumption and apply scaling arguments, such as with 
the effective culture time (ECT) and critical perfusion rate (CPR) described by Young 
and Beebe
117
. Regardless of the method used to estimate the required media exchange 
time scale, experimental validation is typically required depending on the specific cell 
type and microfluidic device configuration.  
Media can be exchanged either by continuous perfusion or at defined intervals. 
The former strategy has been used as a way to regulate diffusible cell signaling and 
investigate its role in regulating cell behaviors
98,99
. For example, autocrine and paracrine 







. Previous work using microfluidic perfusion based approaches has 
shown that cell-secreted signaling is critical for maintenance of mESC pluripotency
99
. In 
contrast, periodic medium delivery, as opposed to continuous perfusion, has been shown 
to be an effective method for supporting cell growth and differentiation
124,125
. Giobbe, et 
al. showed that in the context of hiPSC microfluidic culture, discontinuous media 
perfusion resulted in more homogenous colonies
126
. Furthermore, for differentiation 
towards each of the germ lineages, different discontinuous perfusion rates were found to 








Given this previous work, the objective of this chapter was to explore key 
parameters in microfluidic culture of stem cell aggregates and understand how these 
parameters influence stem cell behavior and differentiation. These studies were done in 
the context of differentiation of embryonic stem cells (ESCs) to motor neurons (MNs). 
This differentiation protocol was chosen because it is well-established
35
, MNs are a 
therapeutically relevant cell type, and there is evidence for roles of cell-secreted signaling 
in promoting differentiation
39,40,127
. Specifically, an approach coupling experimental 
studies and transport modeling was used to assess how media exchange frequency and 
device geometries modulate the biochemical microenvironment, including availability of 
exogenous factors (e.g., nutrients, small molecule additives) and cell-secreted molecules, 
and thereby impact differentiation. The results of these studies demonstrate that 
discontinuous perfusion is effective at supporting stem cell aggregate growth, in 
agreement with previous work with two-dimensional cultures. We find that there is a 
balance between the frequency of media exchange, which is needed to ensure that cells 
are not nutrient-limited, and the need to allow accumulation of cell-secreted factors to 
promote differentiation. Finally, we find that microfluidic device geometries can be 
exploited as a tool to expose aggregates to gradients of cell-secreted factors and promote 








3.2 Materials and Methods 
3.2.1 Device Fabrication 
 
Microfluidic devices were fabricated in polydimethylsiloxane (PDMS) (Dow 
Corning Sylgard 184, Midland, MI) by soft lithography.
71
 Briefly, a master mold was 
fabricated by standard UV photolithography with the negative photoresist SU8-2100 
(Microchem, Newton, MA) to create three layers of respective heights 200 μm, 100 μm, 
and 200 μm. Before PDMS molding, the master was treated with tridecafluoro-1,1,2,2-
tetrahydrooctyl-1-trichlorosilane vapor (United Chemical Technologies, Bristol, PA) to 
allow release of the PDMS. To make devices, PDMS was mixed in a 10:1 ratio of pre-
polymer and crosslinker, degassed to remove air bubbles, poured on the master mold, 
degassed a second time to remove remaining bubbles, and cured for 2 hours at 70 °C. 
Following curing, devices were cut and inlet and outlet holes for fluidic connections were 
punched with 18 gauge blunt needles (McMaster-Carr, Elmhurst, IL). Devices were then 
bonded onto glass coverslips by oxygen plasma bonding. 
3.2.2 mESC Culture 
 
G-Olig2 mESCs were obtained from ATCC® (ATCC SCRC-1037). These cells 
have green fluorescent protein (GFP) inserted into the gene for Olig2. Cells were 
maintained in tissue culture-treated polystyrene dishes (Corning Inc., Corning, NY) 
coated with 0.1% gelatin (Millipore, EmbryoMax). Undifferentiated culture media 
consisted of Dulbecco’s modified Eagle’s medium (DMEM) (Mediatech, Herndon, VA) 
supplemented with 15% fetal bovine serum (Hyclone, Logan, UT), 100 U/mL penicillin, 
100 µg/mL streptomycin, 0.25 µg/mL amphotericin (Mediatech), 2 mM L-glutamine 




betamercaptoethanol (Fisher Scientific, Fairlawn, NJ), and 10
3 
U/mL leukemia inhibitory 
factor (LIF) (ESGRO, Chemicon, Temecula, CA). Cells were passaged at approximately 
70% confluence (typically every 2-3 days) and seeded at a density of 1 million cells for a 
100 mm plate. Culture media was completely exchanged every other day. 
3.2.3 Motor Neuron Differentiation of mESC Aggregates 
 
A single cell suspension of undifferentiated mESCs was obtained by dissociating 
monolayer cultures with 0.05% trypsin-EDTA (Mediatech). Cells were resuspended in 
basal differentiation media that consisted of Dulbecco’s modified Eagle’s 
medium/nutrient mixture F-12 (DMEM/F12) (ThermoFisher Scientific) supplemented 
with 5% Knockout Serum Replacement (ThermoFisher Scientific), 1x Insulin-
Transferrin-Selenium solution (ITS) (ThermoFisher Scientific), 1x MEM non-essential 
amino acid solution (Mediatech), 0.1 mM 2-betamercaptoethanol (Fisher Scientific, 
Fairlawn, NJ), 5 μM thymidine (Sigma-Aldrich), and 15 μM each of adenosine, cytosine, 
guanosine, and uridine (Sigma-Aldrich)
35
.  
Aggregates were formed by centrifugation (200 rcf) of mESCs into 400 μm 
agarose (OmniPur®, EMD Millipore) microwells placed within a 12-well tissue culture 
polystyrene plate (Corning, Inc.).
106
 To yield 1000 cell aggregates, volumes of 0.5 mL of 
the single cell suspension (concentration: 2.4 million cells/mL) were added to each well 
of the 12-well plate.  Cells were incubated in the wells in culture media for approximately 
18-24 hours to allow aggregates to form. Following formation, on day 1 aggregates were 
transferred either to microfluidic devices or Petri dishes. Starting on day 2, media was 
supplemented with 1.5 – 3.0 μM Purpmorphamine (Pur) (Calciobiochem) and 2 – 6 μM 




For batch suspension culture, aggregates were cultured in 100 mm bacteriological 
grade polystyrene Petri dishes (BD, Franklin Lakes, NJ) with approximately 2000 
aggregates per plate in 10 mL of basal differentiation. Plates were maintained on rotary 
orbital shakers (Benchmark Scientific, Edison, NJ) at a frequency of 45 rpm.
15,17
 Media 
was exchanged every other day, with 90% of the media replenished with fresh media. RA 
and Pur were supplemented starting at day 2 and with each additional media change. 
3.2.4 Device Loading and Operation 
 
Prior to each experiment all devices and tubing connections were sterilized by 
autoclaving. Components that could not be autoclaved were either purchased sterile or 
sterilized by ethylene oxide gas treatment. Devices were assembled with a 14 gauge 
dispensing tip with luer lock connection (McMaster-Carr) at the inlet. For priming 
devices with a syringe, a piece of silicone tubing (1/32‖ ID silicone tubing; Cole Parmer) 
was connected to the inlet using 18 gauge polypropylene dispensing needles (McMaster-
Carr). For culture, a sterile 3 mL syringe (Becton Dickinson) with plunger removed was 
screwed onto the inlet to serve as media reservoir. At the device outlet, a blunt 16 gauge 
needle (McMaster-Carr) was connected to a length of silicone tubing. A pinch valve was 
placed on this tubing to allow pressurization of devices to remove bubbles. The silicone 
tubing was connected to a luer lock two-way stop cock (McMaster-Carr) using 
polypropylene needles, and then to an additional length of silicone tubing. Finally, a 0.2 
μm syringe filter (VWR) was connected to the end of the outlet tubing with a 
polypropylene needle to provide a sterile barrier.  
Prior to aggregate loading, devices were first primed with 70% ethanol using a 




saline (PBS) and then incubated with a 1 mg/ml bovine serum albumin (BSA; Millipore) 
solution for 30 minutes to passivate the surfaces.
73,109
 Finally, devices were rinsed with 
basal differentiation media. Aggregates were collected and resuspended at a 
concentration of approximately 600 aggregates/mL in a solution of 1.05 g/mL Percoll 
(Sigma Aldrich) in phosphate-buffered saline (PBS) to prevent rapid settling. Then, 
aggregates were pipetted into the inlet and loaded into devices via gravity-driven flow. 
Once aggregates were loaded, sterile gas permeable adhesive membranes were used to 
seal device inlets (―Breathe-Easier‖, Electron Microscopy Services). Device outlets were 
connected to a syringe pump (PHD 2000; Harvard Apparatus) and the entire setup was 
placed in a humidified incubator (HERAcell 240i, Thermo Scientific). During culture, 
devices were kept in a shallow, sterile water bath to limit evaporation. Devices were 
perfused at a defined flow rate and frequency by withdrawing differentiation media from 
a reservoir at the device inlet using the syringe pump. For continuous media perfusion 
conditions, media was withdrawn at a constant flow rate. For discontinuous media 
perfusion, media was completely exchanged within the device at defined time intervals. 
3.2.5 Immunofluorescent Staining 
 
Immunofluorescent staining was performed in devices by perfusing all solutions 
through the pipette tip inlets by gravity-driven flow. For aggregates cultured in batch 
suspension, all steps were performed in 1.5 mL microcentrifuge tubes, and samples were 
continuously rotated on a tube rotator. First, samples were washed with PBS and fixed in 
10% formalin at room temperature for 40 minutes. Following a wash in block buffer (2% 
BSA, 0.1% Tween 20, in PBS), samples were permeabilized in 1.5% Triton X 100 in 




20, in PBS) for 30 minutes, samples were incubated overnight at room temperature in the 
primary antibody solution: 1:20 Hb9 (81.5C10 from Developmental Studies Hybridoma 
Band) in block buffer or 1:5 Nkx2.2 (74.5A5 from Developmental Studies Hybridoma 
Band) in block buffer. The next day, samples were washed in serum block buffer for 30 
minutes and then incubated in the secondary antibody solution (1:200 AlexaFluor®647 
goat anti-mouse) at room temperature for 4 hours. Samples were washed a final time with 
serum block buffer for 30 minutes and imaged immediately. Device samples were 
imaged in devices; batch suspension culture samples were transferred to glass-bottom 24-
well plates (MatTek Corporation) for imaging.  
3.2.6 Confocal Microscopy 
 
Samples were imaged on a confocal microscope (Zeiss LSM 700 Confocal 
Microscope) with a 20x objective. Z stacks were acquired to a depth of ~50 µm with 
spacings of 5 or 10 µm. For larger aggregates that did not fit in a single field of view, 2x2 
tile scan images with 10% overlap were acquired and stitched together with the 
microscope software (ZEN, Zeiss). For live imaging in devices, device inlets were sealed 
with luer lock caps (McMaster-Carr) to maintain sterility.  
3.2.7 Image Analysis 
 
Confocal images from live and immunostained samples were quantified using 
custom-written MATLAB code. For each aggregate, 5 slices with 10 µm spacing were 
analyzed. Aggregates were first segmented manually from transmitted light images and 
the cross sectional area of each aggregate was measured. The aggregate diameter was 
calculated from the cross sectional area, assuming each cross section to be circular and 




―regionprops‖ function in MATLAB, defined as the ratio of the distance between the foci 
of the ellipse and the major axis length.  
 Individual cells were segmented based on Olig2, Nkx2.2, or Hb9 expression. The 
segmented aggregate image was first used to mask the image. To segment out individual 
cells, a modified version of a method developed by Lou et al. was used
110
. Starting from 
the greyscale image, contrast adjustment was performed as a preprocessing step. Next, 
we applied a Gaussian filter to the image, calculated the Hessian matrix of the resulting 
image, and calculated the first eigenvalue of the Hessian matrix. Then, a threshold was 
applied to the first eigenvalue of the Hessian matrix to eliminate dim pixel values that 
would otherwise result in poor segmentation. The resulting image was used as a mask to 
segment the contrast adjusted greyscale image. This typically yielded slightly under-
segmented cells, so a watershed transform was applied to the masked greyscale cells to 
yield a final, binary image of segmented cells. 
 To quantify Olig2, Nkx2.2, or Hb9 expression for each aggregate, the total pixel 
area of cells expressing that marker for all five z slices was calculated. To yield a metric 
for expression that was normalized by aggregate size, this value was then divided by the 
approximate volume of the portion of the aggregate that was imaged. The volume was 
calculated according to the formula 
   
    
 
       
where h is the height of the sampled region (50 μm) and r is the calculated radius of the 
aggregate. Finally, to compare across multiple conditions, marker expression was 





 To characterize asymmetry in Olig2 expression, the horizontal distance of each 
Olig2+ cell in an aggregate from the centerline of that aggregate was calculated. This 
value was normalized by the aggregate radius. To take into consideration the position of 
each aggregate within its trap, another metric was defined. For this metric, the horizontal 
distance of an Olig2+ cell from the trap entrance was calculated and was normalized by 
the total distance from the opening to back of the trap.  
3.2.8 Statistical Analysis 
 
Statistical analyses were performed using GraphPad Prism software. Statistical 
tests were performed using either a Mann-Whitney U test or non-parametric one-way 
ANOVA (with Kruskal-Wallis) combined with Dunn’s multiple comparison’s test for 
comparison of individual samples. P values less than 0.01 were considered significant. 
3.3 Results and Discussion 
3.3.1 Microfluidic Device Design 
3.3.1.1 Overview of Device Design 
 
To investigate the role of microfluidic culture parameters in differentiation of 
mESC aggregates to motor neurons, the microfluidic device developed in the previous 
chapter was used. This device provided the ability to observe individual stem cell 
aggregates over week-long cultures and to perturb the biochemical microenvironment by 
changing the frequency of media delivery. In this chapter, the device design and external 
fluid handling components were altered to improve device operation, reduce device 





3.3.1.2 Device Design Modifications 
 
The geometry of the device was altered to improve initial aggregate trapping 
(Figure 3.1). The original device design typically loaded with 50% of traps containing 
single aggregates, with remaining traps being empty or containing multiple aggregates
2
. 
It was observed experimentally that aggregates could deform and flow through the small 
resistance channel at the back of the trap, resulting in an empty trap. To address this, the 
resistance channel initial width was reduced from 60 μm to 40 μm, and the height was 
reduced from 200 μm to 100 μm (Figure 3.1b). A consequence of decreasing the 
resistance channel dimensions was that it increased the overall trap fluidic resistance, and 
the ratio of fluidic resistance through the traps in relation to the main channel must be 
balanced for loading of traps
112,113
. To offset the reduced resistance channel dimensions, 
the resistance channel shape was changed: the initial width of the channel was set to 40 
μm and the maximum width to 80 μm (with height remaining constant) (Figure 3.1b). 
This design provided the narrow 40 μm opening needed to prevent aggregates from 




Figure 3.1. Microfluidic device design. a) Schematic illustrates the design of the new, 
modified microfluidic device, with inset depicting the main channel, trap, and resistance 
channel. b) Schematics show key geometries and dimensions of the new design, 





A second design change was implemented to decrease the occurrence of 
aggregates flowing out of traps during culture if fluid flow disturbances occurred (for 
example, while attaching or detaching syringes to the device tubing). To address this, a 
narrowed rectangular region of width 170 μm and height 300 μm was added to the trap 
entrance (Figure 3.1b). The rationale was that as aggregates increased in size during 
culture, they would become physically constrained from exiting the trap upon exposure to 
minor flow disturbances. 
In another design change, the diameter and height of the trap were reduced from 
500 μm to 400 μm (Figure 3.1b). Over the culture time period needed for the studies in 
this chapter (one week), aggregates were not expected to grow larger than 400 μm. 
Reducing the trap size enabled a larger portion of the trap to be captured within the field 
of view of the microscope and more traps to be packed in a smaller device footprint. 
A final design change was made to improve control over the flow rate during 
aggregate loading. Devices are loaded using gravity-driven flow based on a height 
difference between inlet and outlet, and the previous device design needed to be coupled 
in series with a second identical device to increase the overall fluidic resistance to 
achieve the desired flow rate. To avoid the need to use a second device, a serpentine 
channel region was added to the end of the device to increase the overall fluidic 
resistance (Figure 3.1a). The optimal flow rate for loading was determined 
experimentally to be ~ 1 ml/hr. Together with all of the design changes, the loading 
efficiency was increased from 50% to 70% singly-loaded traps. In the new design, the 
ratio of trap to main channel resistance of the new design is ~ 6, compared to ~ 20 with 




3.3.1.3 External Fluid Handling Components 
 
A number of external fluid handling components were added to the device to 
address experimental needs (Figure 3.2). These components addressed requirements 
associated with device priming, device loading, maintaining sterility, and performing 
microscopy on live samples. Importantly, all fluid handling components could be 
sterilized by autoclaving, by ethylene oxide treatment, or were purchased sterile. 
The device inlet was chosen to satisfy requirements associated with priming, 
loading aggregates, and culture. In order to prime devices to remove bubbles prior to 
loading, devices were pressurized with fluid using a syringe screwed onto the luer lock 
connection of the inlet (Figure 3.2). For loading of aggregates and subsequent culture, a 
standard 3 mL syringe with the plunger removed was screwed on to the device inlet as a 
media reservoir. This provided a volume large enough that that the reservoir needed to be 
filled only once per day or less.  
Two types of valves were used. The pinch valve was used during priming to 
maintain pressurization of the device. During aggregate loading and in all following 
device manipulations, the two-way valve was used to stop flow through the device as 
opposed to the pinch valve. The pinch valve displaced fluid back into the device that 
could dislodge trapped aggregates, whereas the two-way valve displaced a minimal 
amount of fluid.  
To perfuse media at a defined rate and frequency during culture, the outlet tubing 
was connected to a syringe on a syringe pump. The pump was programmed to withdraw 




Finally, during experiments, devices containing live aggregates needed to be 
transported sterilely between biosafety cabinets, incubators, and microscopes. The 
syringe filter at the device outlet provided a sterile barrier, and sterile, gas-permeable 
adhesive film was used to create a sterile barrier at the opening to the media reservoir. 
For live microscopy, the media reservoir could be unscrewed from the device inlet and 
the device inlet sterilely sealed with a luer lock connector in order to fit on a confocal or 




Figure 3.2. Device and external fluid handling components. Photograph depicts the 
microfluidic device and external components, including the inlet and media reservoir, 
valves, outlet tubing, and filter.  
3.3.2 Differentiation under Continuous and Discontinuous Perfusion 
3.3.2.1 Overview 
 
To investigate the role of the microfluidic media exchange method on mESC 
motor neuron differentiation, we differentiated mESC aggregates according to an 
established protocol
35,44,127
. Aggregates were formed from G-Olig2 mESCs in basal 




acid (RA) and sonic hedgehog agonist purmorphamine (Pur) were added to the media 
starting at day 2 and with every successive media change to promote motor neuron 
differentiation (Figure 3.3). The fluorescent reporter cell line enabled assessment of 
Olig2 expression, a marker for progenitor motor neurons (pMNs), in live aggregates.  
 
 
Figure 3.3. Differentiation of mESC aggregates to motor neurons. a) Cartoon depicts the 
differentiation of mESCs first to pMNs marked by Olig2 and then to either Hb9+ MNs or 
Nkx2.2+ OPCs. b) Schematic shows the differentiation protocol used. 
 
We hypothesized that discontinuous media perfusion would be more effective at 
supporting cell growth than continuous media perfusion, due to the ability of continuous 
perfusion to alter diffusible cell signaling. To test this, we compared discontinuous 
perfusion at a frequency of         (e.g. exchanging media once per day) to 
continuous perfusion at a rate of 10 μL hr
-1 
and assessed cultures at day 7 of 
differentiation. For discontinuous perfusion, there was no media flow in devices except 
during media exchange. For this condition, every 24 hours media within devices was 
completely exchanged by manually flushing ~4 device volumes worth of media through 
each device. The day 7 time point was chosen based on preliminary experiments (not 
shown) indicating that this was when generation of Olig2+ pMNs could best be observed. 
3.3.2.2 Aggregate Size and Morphology 
 
To assess cell growth, we characterized aggregate size and morphology. 




field images (Figure 3.4a). Aggregates cultured at         were slightly smaller on 
average than plate controls, but this difference was not statistically significant. In 
contrast, aggregates cultured at 10 μL hr
-1 
were significantly smaller than plate controls 
(p<0.0001). As a descriptor of aggregate shape, eccentricity was calculated from bright 
field images (Figure 3.4b). Aggregates cultured at         had less circular 
morphologies than plate controls (p<0.01). This is likely explained by the observation 
that aggregates could conform to segments of the trap wall, resulting in non-circular 
shapes. In contrast, aggregates cultured at 10 μL hr
-1 
were similar in shape to controls. As 
aggregates in this condition remained small, influences of trap shape had little to no 
effect. Overall, this data indicates that cell growth was not statistically significantly 
different between cultures at         and plate controls, but growth under culture at 10 
μL hr
-1
 was reduced. Two possible explanations for the reduced growth are that cells 
were nutrient limited or that continuous perfusion removed cell-secreted molecules 
necessary for growth. To explore which of these two possibilities explained the data, a 
transport modeling analysis was next performed. 
 
 
Figure 3.4. Effects of media perfusion method on morphology. a) Aggregate cross-
sectional area was measured from bright field images at day 7. b) Aggregate eccentricity 
was measured from bright field images at day 7. Continuous: n = 58 from 2 devices; Plate 




indicate SEM. Kruskal-Wallis test with Dunns multiple comparisons was used. * 
indicates p < 0.01; *** indicates p < 0.0001. 
3.3.2.3 Transport modeling analysis 
 
One possible explanation for reduced growth is that cells were nutrient limited. 
To investigate whether either of the media exchange conditions was likely nutrient 
limiting, relevant transport parameters were calculated. For continuous perfusion, we 
calculated the time scale,     , for glucose to be completely consumed by all aggregates 
in the device. We defined                                                     where 
         is the initial glucose concentration,         is the device volume,           is the 
cell consumption rate of glucose,             is the number of aggregates, and        is 
the number of cells per aggregate
117
. Values for these parameters are listed in Table 3.1. 
We found that        50 hours. This time scale for glucose consumption was compared 
to the convective time scale,                   where         is the linear length 
through the main serpentine channel of the device and    is average linear velocity for 
continuous perfusion. This convective time scale represents the residence time of a fluid 
element flowing through the main channel of the device. We found that         0.75 
hours. These calculations indicate that the time scale of convection is much faster than 
that of glucose consumption. Therefore, there is likely sufficient delivery of a nutrient 
such as glucose at this perfusion rate. Furthermore, nutrients are likely not depleted by 
aggregates upstream in the device before media reaches aggregates at the outlet. 
To assess whether the time interval between media exchanges was sufficient for 
discontinuous perfusion, we again calculated the time scale,     , for glucose to be 
completely consumed in the device. This value was the same as for continuous perfusion: 




As fluid shear stress can modulate cell behavior, we calculated the shear stress for 
all perfusion conditions tested. Shear stress is defined as               where   is 
fluid shear stress,   is viscosity of water,   is the volumetric flow rate,   is the main 
channel height, and   is the main channel width. For the range of device operating 
conditions, shear stress was within                        . As operation at shear 
stresses             is considered not likely to affect cell phenotype100, we assumed 
shear did not have effects in our system.  
Based on these transport calculations, we concluded that reduced aggregate 
growth in culture under continuous perfusion was not due to nutrient restrictions, but 
rather due to perfusion-based removal of cell-secreted factors necessary for growth. To 
assess whether continuous perfusion can remove cell-secreted factors, we calculated the 
Peclet number,   , which represents the ratio between convection and diffusion. We 
defined                                  where            is the trap depth,    is the 
average linear fluid velocity, and                  is the diffusion coefficient of a growth 
factor. For this calculation, we used    for the main channel—a simplified assumption, as 
velocity changes with position in the device. Expected actual variations in this velocity 
ultimately did not impact the calculated Peclet number significantly. For continuous 
perfusion, we calculated      for transport of a cell-secreted molecule such as a 
growth factor, indicating that convection dominates and can indeed perturb cell-secreted 
signaling. This conclusion is supported by previous work that demonstrated inhibition of 
cell growth under continuous perfusion conditions
99
. These results highlight how nutrient 




requirements that ultimately need to be balanced in designing operating conditions for a 
microfluidic device. 
 
Table 3.1: Transport modeling parameters 
Parameter Name Symbol Value 
Diffusion coefficient, glucose
128
                        




                             
Viscosity, water              
              
Consumption rate, glucose
128
                               
Consumption rate, growth factor
129
                                     
Initial concentration, glucose                          
Trap depth                   
Trap height                     
Channel width and height                 
Total channel length          80 mm 
Volume of trap               
Volume of device               
Number of cells per aggregate             
Number of aggregates per device                
Average linear velocity,  
continuous perfusion 
          
   
Average linear velocity, 
discontinuous perfusion 
           
   
 
3.3.2.4 Differentiation of pMNs 
 
To assess how media perfusion method impacted differentiation of mESCs to 
pMNs, we next assessed Olig2 expression at day 7 of culture under the same two 




this time point. Preliminary experiments (not shown) with this differentiation protocol in 
batch culture indicated that day 7 was a relevant time point for assessments. As seen in 
the representative confocal microscopy images (Figure 3.5a), little Olig2 expression was 
observed in both the         and 10 μL hr-1 conditions, whereas many Olig2+ cells 
were observed in plate controls. The amount of Olig2 expression for individual 
aggregates in each condition was quantified using image processing (Figure 3.5b). 
Quantification revealed that there was no Olig2 expression in 10 μL hr
-1
 cultures, which 
the exception of three outliers. Examination of the data provided no explanation for the 
existence of these outliers. Olig2 expression was slightly higher in         cultures, 
but the difference compared to 10 μL hr
-1
 was not statistically significant, likely due to 
the three outlying aggregates. For both perfusion conditions, Olig2 expression was 
significantly lower than plate controls (p < 0.0001).  
 
Figure 3.5. Effect of media perfusion method on differentiation of pMNs. a) 
Representative images from a single confocal slice of Olig2 expression at day 7 and 
corresponding bright field images. All scale bars are 100 μm. b) Normalized Olig2 
expression quantified for each condition. Continuous: n = 58 from 2 devices; Plate 




Error bars represent SEM. Kruskal-Wallis test with Dunns multiple comparisons was 
used. *** indicates p < 0.0001. Plate controls were n.s. 
3.3.2.5 Effects of Aggregate Size and Device Position on pMN Differentiation 
 
We next investigated whether there were any trends between Olig2 expression 
and other parameters for         cultures. We did not assess 10 μL hr-1 cultures since 
expression levels were so low. We measured the correlation between Olig2 expression 
and aggregate size (Figure 3.6a) by calculating the Spearman rank correlation. The 
Spearman correlation coefficient ranges from -1 to +1; values of +1, 0, and -1 indicate 
total positive, no, and total negative correlations, respectively.  As summarized in Table 
3.2, aggregate size and Olig2 expression was not significantly correlated for device 
cultures (R=0.033; n.s.) but was positively correlated for plate controls (R=0.66; 
p<0.001).  
Table 3.2: Spearman Rank Correlation Analysis of Olig2 Expression and Aggregate Size 
Condition Spearman correlation coefficient P value 
        R = 0.033 n.s. 




Figure 3.6. Effects of aggregate size and device position on pMN differentiation. a) 
Correlation between aggregate area and normalized Olig2 expression at day 7. b) 
Normalized Olig2 expression for aggregates in a single representative device plotted 
based on position in the device. Traps are numbered with respect to position along the 





 Next, we assessed if there was a relationship between Olig2 expression of a given 
aggregate and its location in the device. In Figure 3.6b, Olig2 expression for a given 
aggregate is plotted in relation to that aggregate’s position. Traps are numbered 
sequentially based on position following the main channel, with trap 1 at the inlet and 
trap 105 at the outlet. Although there is variability in Olig2 expression among aggregates, 
there is no clear correlation with position.  
3.3.2.6 Discussion 
 
Overall, these data indicate that both of these media exchange conditions do not 
promote differentiation of large populations of pMNs. For the reduced cell growth and 
minimal pMN differentiation observed for the 10 μL hr
-1
 condition, transport modeling 
and previous literature supports a proposed mechanism that continuous perfusion alters 
autocrine/paracrine signaling required both for growth and differentiation. The minimal 
pMN differentiation observed for         was an unexpected result. Transport 
modeling suggested that this was likely not due to nutrient limitations, so we next 
explored how additional perturbations of endogenous and exogenous signaling would 
influence pMN differentiation. 
3.3.3. Effects of increasing RA and Pur Delivery on pMN Differentiation 
3.3.3.1 Overview 
 
Following the initial assessment of pMN differentiation under continuous and 
discontinuous perfusion, we hypothesized that lower effective concentrations of RA and 
Pur in microfluidic devices may have contributed to the minimal differentiation that was 






. The tendency of PDMS to absorb a given molecule (the partition 
coefficient) is related to the logarithm of the octanol-water partition coefficient (logP) of 
that molecule
132
. In a study conducted by Wang et al.
132
, molecules with logP < 2.5 
exhibited low absorption into PDMS (<25% after 4.5 hours) and molecules with 
logP>2.5 exhibited high absorption (>75% after 0.5 hours). RA and Pur have logP values 
of 6.30 (source: Sigma-Aldrich) and 7.58 (source: EPA
133
), respectively, and therefore 
are potentially highly absorbed by PDMS.  
To evaluate whether increased delivery of RA and Pur to microfluidic cultures 
could promote increased pMN differentiation, we differentiated mESC aggregates under 
discontinuous perfusion at         (e.g. exchange media every 8 hours) at three-fold 
increased RA and Pur concentrations (6 μM and 3 μM, respectively). This condition was 
chosen to increase both nutrient and RA/Pur delivery. Media was exchanged in devices at 
this discontinuous perfusion frequency by flushing media through devices once every 8 
hours at a flow rate of 200 µL hr
-1 
for a duration of 24 minutes. For comparison, we 
differentiated plate controls at both the original (2 μM RA; 1.5 μM Pur) and new 
concentrations (6 μM RA; 3 μM Pur).  
3.3.3.2 Aggregate Size and Morphology 
 
To assess aggregate growth and morphology, we quantified aggregate cross-
sectional area and eccentricity. Aggregate size in         cultures was comparable to 
plate controls cultured at the same concentration but lower than plate controls cultured at 
the original RA and Pur concentrations (Figure 3.7a). This suggests that both the culture 
format and concentrations of RA and Pur affect cell growth. Quantification of 




morphology than both sets of plate controls (Figure 3.7b). This observation matched that 
for         cultures—that aggregates tend to adopt the shape of portions of the trap as 
they grow, resulting in increased non-circular morphologies.  
 
 
Figure 3.7. Effects of discontinuous perfusion and RA and Pur concentrations on 
morphology. a) Aggregate cross-sectional area was measured from bright field images at 
day 7. b) Aggregate eccentricity was measured from bright field images at day 7. 
Discontinuous device: n = 94 from 2 devices. Plate control (6 µM/3 µM): n = 58. Plate 
control (2 µM/1.5 µM): n = 37. Error bars indicate SEM. Kruskal-Wallis test with Dunns 
multiple comparisons was used. * indicates  < 0.01; *** indicates p < 0.0001.  
3.3.3.3 Differentiation of pMNs 
 
We next assessed the effects of increasing RA and Pur delivery on differentiation 
of pMNs at day 7. We observed increased Olig2 expression in         cultures 
compared to         cultures, as shown in the representative images (Figure 3.8a). 
Quantification of Olig2 expression indicated that in         the mean expression level 
was comparable to plate controls cultured at the same concentration (6 μM RA; 3 μM 
Pur) but lower than the mean level of expression in plate controls cultured at the original 
RA and Pur concentrations (2 μM RA; 1.5 μM Pur) (p<0.0001; Figure 3.8b).  Variability 
in the amount of Olig2 expression was observed across all experimental groups. 




including a sub-population of aggregates with no Olig2 expression (Figure 3.8b). Plate 
controls also exhibited a range of expression levels. 
The increase in pMN differentiation in microfluidic cultures with increased 
delivery of RA and Pur supports the hypothesis that effective concentrations of these 
exogenous factors were likely lower in devices compared to plate controls. These small 
molecules are likely absorbed by PDMS, as literature suggests
130,131
, and the data 
presented here suggests that this effect can be partially compensated for by increasing 
concentration and delivery frequency. In plate controls, we observed that the amount of 
pMN differentiation in plate controls was reduced by increasing concentrations of RA 
and Pur to 6 μM and 3 μM respectively. During embryonic development, gradients of 
Shh signaling produce different progenitor domains, one of which consists of pMNs
35
. 
Previous work has shown that changing the concentration of Pur, a Shh agonist, affects 
numbers of Olig2+ pMNs generated
44
. Although this was not characterized in these 
experiments, it is likely that increasing the Pur concentration in plate controls shifted 






Figure 3.8. Effects of discontinuous perfusion and RA and Pur concentration on 
differentiation of pMNs. a) Representative images from a single confocal slice of Olig2 
expression at day 7 and corresponding bright field images. All scale bars are 100 μm. b) 
Normalized Olig2 expression quantified for each condition. Discontinuous device: n = 91 
from 2 devices. Plate control (6 µM/3 µM): n = 58. Plate control (2 µM/1.5 µM): n = 33. 
Error bars represent SEM. Kruskal-Wallis test with Dunns multiple comparisons was 
used. *** indicates p < 0.0001. 
 
3.3.3.4 Effects of Aggregate Size and Device Position on pMN Differentiation 
 
We next investigated whether there were any trends between Olig2 expression 
and other parameters for         cultures. As before, we measured the correlation 
between Olig2 expression and aggregate size (Figure 3.9a) by calculating the Spearman 
rank correlation. As summarized in Table 3.3, aggregate size and Olig2 expression was 
significantly correlated for all three experimental groups: device cultures (R=0.34; 
p<0.001), plate controls at the same supplemented concentration (R=0.35; p<0.001), and 
plate controls at the lower concentration (R=0.44; p<0.01).  
 








        
6 μM RA, 3 μM Pur 
R = 0.34 P < 0.001 
Plate control 
6 μM RA, 3 μM Pur 
R = 0.35 P < 0.001 
Plate control 
2 μM RA, 1.5 μM Pur 
R = 0.44 P < 0.01 
 
We also assessed if there was a relationship between Olig2 expression of a given 
aggregate and its location in the device. In Figure 3.9b, Olig2 expression for a given 
aggregate is plotted in relation to that aggregate’s position. Traps are numbered 
sequentially based on position following the main channel, with trap 1 at the inlet and 
trap 105 at the outlet. Although there is variability in Olig2 expression among aggregates, 
as with          cultures. There is no clear correlation with position.  
 
 
Figure 3.9. Effects of aggregate size and device position on pMN differentiation. a) 
Relationship between aggregate area and normalized Olig2 expression at day 7. b) 
Normalized Olig2 expression for aggregates in a single representative device plotted 
based on position in the device. Traps are numbered with respect to position along the 
serpentine channel, with trap 1 at the inlet and trap 105 at the outlet. 
 
3.3.3.5 Differentiation of MNs and OPCs 
 
As it is known that during differentiation pMNs generate both MNs and OPCs, we 
next wanted to investigate whether these cell types were generated in the         




the MN marker Hb9. Hb9 expression was observed both in microfluidic cultures and in 
plate controls, as seen in the representative images (Figure 3.10a). Quantification of Hb9 
expression using image analysis showed culture format and concentration dependent 
effects (Figure 3.10b). Microfluidic cultures (       ; 6 μM RA, 3 μM Pur) on 
average expressed Hb9 at low levels, with some variability in amount of expression. Plate 
controls at the same supplemented concentration of small molecules (6 μM RA, 3 μM 
Pur) had slightly higher levels of Hb9 expresison (p<0.0001). Plate controls at lower 
small molecule concentrations (2 μM RA, 1.5 μM Pur) had the highest levels of Hb9 
expression (p<0.001).  
 
Figure 3.10. Effects of discontinuous perfusion and RA and Pur concentration on 
differentiation of committed MNs. a) Representative images from a single confocal slice 
of normalized Hb9 and Olig2 expression at day 7 and corresponding bright field images. 
All scale bars are 100 μm. b) Normalized Hb9 expression quantified for each condition. 
Discontinuous device: n = 37 from 1 device. Plate control (6 µM/3 µM): n = 25. Plate 
control (2 µM/1.5 µM): n = 14. Error bars represent SEM. Kruskal-Wallis test with 
Dunns multiple comparisons was used. ** indicates p < 0.001; *** indicates p < 0.0001. 
In the same experiment, we assessed generation of OPCs by performing 
immunostaining for Nkx2.2. As depicted in the representative images (Figure 3.11a) and 




levels in microfluidic cultures and plate controls at the same supplemented RA and Pur 
concentration. Nkx2.2 expression was much higher in plate controls at the higher RA and 
Pur concentrations (p<0.0001 versus microfluidic culture; p<0.01 versus plate controls at 
the higher concentration).   
 
Figure 3.11. Effects of discontinuous perfusion and RA and Pur concentration on 
differentiation of OPCs. a) Representative images from a single confocal slice of 
normalized Nkx2.2 and Olig2 expression at day 7 and corresponding bright field images. 
All scale bars are 100 μm. b) Normalized Nkx2.2 expression quantified for each 
condition. Discontinuous device: n = 56 from 1 device. Plate control (6 µM/3 µM): n = 
23. Plate control (2 µM/1.5 µM): n = 15. Error bars represent SEM. Kruskal-Wallis test 
with Dunns multiple comparisons was used. * indicates p < 0.01; *** indicates p < 
0.0001. 
3.3.3.6 Discussion  
 
Together, this data demonstrates that pMNs give rise to both MNs and OPCs in 
these cultures. In the microfluidic cultures, amounts of both cell types are lower than in 
plate controls, and in particular, microfluidic cultures show very little differentiation of 








For microfluidic-based culture and analysis of stem cell aggregates, device 
designs that incorporate physical traps or chambers
76,86,87
 to isolate aggregates, such as 
the design used in this chapter, are common. The advantage of these types of designs is 
that they can be used to prevent physical interactions between aggregates and they enable 
observation of phenotypes through time. However, geometries of traps or chambers can 
influence the biochemical microenvironment, based on how they influence media 
exchange characteristics. Indeed, Khoury et al.
86
 has shown how culturing hESC 
aggregates in microfluidic traps allowed for the formation of biochemical gradients. 
Given the potential for interactions among device asymmetrical geometries and media 
transport properties to produce differences in the biochemical microenvironment, we 
sought to characterize these for our system.  
Due to the design of the microfluidic platform, there is potential for trapped 
aggregates to be asymmetrically exposed to media flow. At earlier time points, when 
aggregate diameter is much less than the trap size, media exchange through the trap is 
convection-based. However, as aggregate diameter increases throughout culture, 
aggregates can grow large enough to partially or completely block flow through the traps. 
When flow through a trap is completely blocked, media is exchanged solely by diffusion. 
In this case, gradients of both nutrients and cell-secreted factors can form that potentially 





3.3.4.2 Spatial Characterization of pMN Differentiation 
 
To investigate whether biochemical gradients were present in our microfluidic 
system that affected differentiation of pMNs, we assessed spatial patterns of Olig2 
expression. We examined data from two microfluidic culture conditions: discontinuous 
perfusion at         (with 3 μM RA, 1.5 μM Pur) and discontinuous perfusion at 
        (with 6 μM RA, 3 μM Pur).  
To first assess if flow of media through traps was hindered by aggregates, we 
manually curated bright field images of aggregates at day 7 of differentiation, the day that 
pMN expression was measured. For each culture condition, we counted the number of 
aggregates that were large enough or positioned such that they likely at least partially 
reduced media flow through the trap. We found that 65% of aggregates in         
cultures and 79% of aggregates in         cultures likely reduced media flow through 
the traps (Table 3.4). This indicated that it was possible by day 7 of differentiation that 
there was reduced media flow through the traps. 
 
Table 3.4: Percentages of aggregates blocking flow through traps 
Condition 
% aggregates reducing 
flow through traps 
        
3 μM RA, 1.5 μM Pur 
65% 
        
6 μM RA, 3 μM Pur 
79% 
 
To assess if reduced media flow through traps could produce biochemical 
gradients of cell-secreted molecules, we calculated the diffusion time scale for a 
representative growth factor, using parameters available for the growth factor EGF. Time 




and  is the diffusion coefficient. Using values from Table 3.1, we calculated the time 
scale of diffusion of a growth factor to be ~4 hours. Given that media was exchanged 
every 8 hours or every 24 hours for the two conditions tested, this diffusion time scale 
suggested that gradients of cell-secreted factors could potentially form between media 
exchanges. 
We hypothesized that if biochemical gradients were present, they would alter cell 
phenotypes in aggregates according to spatial proximity to the main channel, where 
media was exchanged. To assess if this was indeed the reason, we quantified the 
horizontal distance of each Olig2+ cell in an aggregate from the centerline of that 
aggregate (Figure 3.12a). This value was normalized the aggregate radius, calculated 
from the measured cross-sectional area. In Figure 3.12b-e, the histograms show the 
relative frequency of Olig2+ cells at a given horizontal differentiation from the aggregate 
centerline, where 0 is the aggregate centerline, positive x values indicate cells closer to 
the trap entrance, and negative x values indicate cells closer to the back of the trap. Each 
plot reflects population-level data from all aggregates for that condition. For aggregates 
cultured at        , Olig2+ cells appeared to be localized in regions on both sides of 
the aggregate centerline, with a slightly larger peak of cells in regions closer to the backs 
of traps (Figure 3.12b). Assessment of histograms for individual aggregates (Appendix 
B.1) showed that individual aggregate spatial distributions were varied. Some had Olig2 
expression in regions closer to the trap entrance, some had expression closer to the trap 
back, and some had expression throughout. For aggregates cultured at        , a larger 
proportion of Olig2+ cells were located in regions of aggregates closer to the backs of 




(Appendix B.3,4), despite there being some variability. In contrast to microfluidic 
cultures, in plate controls at both RA and Pur concentrations Olig2+ cells were 
distributed symmetrically through aggregates (Figure 3.12d,e). The slight asymmetry in 
the distributions appeared to be a result of individual aggregate heterogeneity (Appendix 
B.7,8).  
Manual curation of this data was performed to identify potential correlations 
between spatial location of Olig2 expression and aggregate size, aggregate position 
within trap, or aggregate position within the device. However, this analysis revealed no 
clear trends. Additionally, to assess any effects associated with position of an aggregate 
within a trap, we quantified positions of Olig2+ cells in a given aggregate with respect to 
the reference frame of the trap. Measuring the horizontal distance of each Olig2+ cell 










Figure 3.12. Effects of discontinuous perfusion frequency on spatial characteristics of 
Olig2 expression. a) Image describes how metric is quantified. Histograms show 
population-level data for horizontal position of Olig2+ cells with respect to aggregate 
center line for (b) discontinuous perfusion (f = 1 d
-1
) with 2 μM RA and 1.5 μM Pur (n = 
31 from 1 device), (c) discontinuous perfusion (f = 3 d
-1
) with 6 μM RA and 3 μM Pur (n 
= 47, representative of 2 devices), (d) plate controls with 2 μM RA and 1.5 μM Pur (n = 
13), and (e) plate controls with 6 μM RA and 3 μM Pur (n = 25). 
3.3.4.3 Discussion 
 
Spatial characterization of Olig2 expression revealed differences in aggregates 




in where Olig2 expression was localized in relation to the trap geometry. If there were 
local gradients in cell-secreted factors for this media exchange condition, these did not 
produce clear trends in the data. In contrast, in aggregates cultured at          and 
increased RA and Pur concentrations, there was more Olig2 expression in regions of 
aggregates further away from the main channel. This data supports our hypothesis that 
when aggregates restrict media flow through traps, local gradients of cell-secreted factors 




This chapter explored how key parameters of microfluidic culture of stem cell 
aggregates influenced cell growth and differentiation. Media exchange strategy was 
found to be a key parameter in modulating cell growth and differentiation of mESCs to 
pMNs. Continuous media perfusion resulted in less cell growth and minimal generation 
of pMNs, which we proposed was due to modulation of diffusible autocrine/paracrine 
signaling and not a consequence of nutrient limitations. This finding is in agreement with 
previous work
98,99,126
. Differentiation under discontinuous media perfusion was shown to 
promote differentiation of pMNs, MNs, and OPCs, although not to the level of plate 
controls. In addition, the discontinuous media perfusion frequency and concentrations of 
small molecules added to the media were identified as parameters influencing the amount 
of pMNs generated. We proposed that discontinuous media perfusion better supported 
differentiation by allowing accumulation of cell-secreted factors required for cellular 




understanding how microfluidic media exchange conditions modulate growth and 
differentiation of mESC aggregates. 
These studies also highlighted a disadvantage of using PDMS as a material for 
microfluidic cell culture. It is well-known that PDMS can absorb small molecules, 
particularly hydrophobic molecules
131
. However, the many advantages of using PDMS, 
including optical clarity, ease of fabrication, and cost still make it an attractive material 
for use in microfluidic devices for cell culture. Thus, care should be taken in design of 
any PDMS-based cell culture system to address this particular disadvantage of PDMS. 
Our results demonstrate that PDMS absorption of small hydrophobic molecules can be 
partially compensated for by altering concentration and delivery frequency of those 
molecules.  
Finally, these studies revealed how asymmetrical microfluidic device geometries 
can be used to create local gradients of soluble factors and influence phenotypes spatially. 
The data demonstrated that diffusion-dominated media exchange in aggregate traps could 
create local concentration differences in soluble molecules and that these could influence 
spatial patterns of pMN differentiation. This effect was dependent on media perfusion 
frequency. This finding has implications for applications in spatial patterning of tissues 








CHAPTER 4 : DESIGN AND VALIDATION OF A PLATFORM FOR CULTURE 




In this chapter, miniaturized platforms for culture and assessments of forebrain 
organoids were developed. The platforms enable culture of organoids in individual 
chambers, controlled delivery of media and reagents, access for imaging-based assays, 
and retrieval of organoids for end-point based assays. Use of the platforms for generation 
of forebrain organoids was validated through characterization of growth, morphology, 
cell types, and structural features following up to 42 days of culture. This work was 
performed in collaboration with the lab of Dr. Zhexing Wen at Emory University. 
4.1 Introduction 
Studying human brain development and disease is challenging because of the lack 
of robust human-specific models. Animal models have been used widely to gain insights 
into brain development; however, many diseases are difficult to recapitulate in animal 
models, and the lack of human-specific physiology has limited translation of findings 
from animal models to the development of therapeutics. Recently, methods have been 
developed to generate three-dimensional (3D) models of human brain tissues from 
induced pluripotent stem cells (iPSCs)
52
. These models, termed cerebral organoids, rely 
on the self-organizing capabilities of iPSCs and recapitulate key tissue-specific features 
of cellular assembly, integration, and organization. Because of their unique properties, 
cerebral organoids provide an exciting opportunity to model human brain development 
and disease. 
Despite the exciting potential of cerebral organoids, there are a number of major 




consuming, and costly nature of organoid culture procedures. Protocols for organoid 
formation and culture require manual manipulations, such as the embedding of individual 
organoids in Matrigel. Commonly used culture formats include spinning bioreactors
52
, 
tissue culture plates, miniaturized spinning bioreactors
56
, and multiwell plates. Spinning 
bioreactors require large volumes of costly media and take up significant space, which is 
prohibitive for screening. Alternatives such as miniaturized spinning bioreactors, tissue 
culture plates, and multiwell plates allow use of smaller media volumes and multiplexing 
but still present cost and space issues for large-scale screening.  
A second challenge is the extensive heterogeneity observed among cerebral 
organoids. Within cultures, organoids vary widely in terms of features such as size, 
diversity of cell types present, and structural features. This variability complicates 
quantitative analyses and limits applicability of cerebral organoids in screening. 
Understanding how to generate cerebral organoids more robustly is an active area of 
research, but there is still a lack of understanding of the mechanisms governing organoid 
formation and how heterogeneity can be controlled.  
A third challenge associated with current cerebral organoid technologies is the 
inability to perform in situ phenotypic and functional assays. Typically organoids are 
assessed in end-point based assays. These include immunostaining in intact organoids or 
slices to assess protein expression, cell types, and structural features. Techniques such as 
RNA sequencing to assess transcriptomic information are also used. Imaging-based end-
point assays are currently not incorporated in culture platforms. However, doing so would 
save time and labor associated with manipulating individual organoids and make it easier 




development of imaging-based methods to assess development of live organoids during 
culture is necessary for betting assessing organoid development and performing large 
scale screens.  
Micro- and mesoscale technologies are well-suited to address many of the 
challenges associated with generation and study of cerebral organoids. Reducing the size 
of the culture platform improves scalability: more experimental conditions can be 
assessed at once because conditions can be multiplexed, and less space is required to 
scale the number of cultures performed in parallel. The capabilities of microfluidics for 
spatiotemporal control of the cell culture environment can also be leveraged. 
Microfluidics provides the ability to precisely control delivery of media and reagents to 
cell cultures at defined rates and frequencies—something that cannot be done with 
conventional culture methods. Microfluidic technologies are also compatible with almost 
all modes of microscopy, and microscopy and immunocytochemistry are particularly 
useful for assessments of organoids. 
Although there is a large body of literature in microfluidic technologies for 
culture of cell aggregates, culture of cerebral organoids presents unique considerations. 
Organoids grow much larger than other types of cell aggregates, up to a few millimeters 
in diameter, requiring meso-scale geometries. Additionally, method of media exchange is 
important in order to delivery sufficient nutrients to these large tissues
128,134
. To date, 
very few publications have reported development of a microfluidic platform for cerebral 
organoid culture, or culture of any organoid type. Zhu et al.
89
 developed an array of 
micropillars in which they could both form and culture cerebral organoids. A key feature 




the need for manual manipulations required by conventional embedding methods. One 
drawback of this culture system, however, is that individual organoids cannot be exposed 
to different conditions, a feature which is desired for screening of different drugs or 
compounds. Additionally, while the pillar distance can be tuned for formation of 
organoids of defined sizes, the pillar spacing required for formation will constrict size of 
organoids during long-term culture. Wang et al.
90,91
 developed a microfluidic platform in 
which organoids could be cultured in a center chamber, embedded in Matrigel, 
surrounded by two side channels for diffusive delivery of media and drugs. The 
disadvantage of this platform design is also that organoids are not individually 
addressable for screening.  
In this chapter, we present a microfluidic platform for culture and screening of 
brain organoids. We focused specifically on culture of forebrain organoids which can be 
used to study a variety of developmental disorders.
56
 A close collaboration with Dr. 
Zhexing Wen at Emory University, who studies brain and forebrain organoids, motivated 
this decision. The platform developed in this chapter enables culture of organoids in 
individual chambers, controlled delivery of media and reagents, access for imaging-based 
assays, and retrieval of organoids for end-point based assays. With the first iteration of 
the platform design, we demonstrated culture of forebrain organoids for up to 42 days. 
Characterization of organoid size, morphology, cell types, and structural features 
revealed that organoids cultured in the microfluidic platform developed comparably to 
conventional methods. We then developed a second iteration of the platform design, 
which provides the ability to fluidically isolate individual organoids, is easily 




design based on the footprint of a 96-well plate. We validated forebrain organoid culture 
in this second design and characterized organoid size and morphology. Together, the 
work presented in this chapter establishes a novel microfluidic-based platform technology 
for culture and assessments of forebrain organoids. This technology sets an important 
basis for future work focusing on developing ways to more robustly generate organoids 
and on large-scale screens of organoids for studying human brain development and 
disease.   
4.2 Materials and Methods 
4.2.1 Device Fabrication 
4.2.1.1 General Fabrication Method 
 
Device designs were drawn in SolidWorks, and molds for the devices were made 
using 3D printing by the company Protolabs. Protolabs was consulted in choosing the 
materials for the molds, based on minimum feature size and size of the entire device 
footprint. Molds for the first generation design were printed in the material MicroFine 
Green to accommodate the minimum ~200 μm feature size of the design. Molds for the 
second generation design, which had a minimum 600 μm feature size, were printed in the 
material Accura SL 5530, which was cheaper and could accommodate the larger device 
footprint.  
Using the 3D printed molds,  microfluidic devices were fabricated in 
polydimethylsiloxane (PDMS) (Dow Corning Sylgard 184, Midland, MI) by soft 
lithography.
71
 Molds were not pre-treated prior to use. PDMS was mixed in a 10:1 ratio 
of pre-polymer and crosslinker, degassed to remove air bubbles, poured on the master 
mold, degassed a second time to remove remaining bubbles, and cured for approximately 




warping of the molds over time. The heat deflection temperatures of MicroFine Green 
and Accura SL 5530 are 59°C and 70°C, respectively. Following curing, PDMS devices 
were peeled off of the master molds.  
4.2.1.2 Fabrication Specific to the First Device Design 
 
For the first device design, PDMS was poured on the mold to a height of 5 mm to 
define the height of the culture chamber. Following curing and peeling, the cylindrical 
chambers were made by manually punching holes with a 5 mm biopsy punch (VWR). 
Inlet and outlet holes were punched with a 1 mm biopsy punch (VWR). Devices were 
thermally bonded to a piece of PDMS to seal the side of the culture chambers opposite 
the fluidic channels.  
4.2.1.3 Fabrication Specific to the Second Device Design 
 
The second device design required two-layer PDMS fabrication. The mold for 
both layers was identical, however. For the bottom layer of features, PDMS was poured 
on the mold to a height of 5 mm to define the height of the culture chamber. For the top 
layer of features, the height of the PDMS was not critical but was typically poured to ~2 
mm in height. Following curing and peeling, cylindrical chambers were made in the 
bottom feature layer by manually punching holes with a 5 mm biopsy punch (VWR). The 
top and bottom PDMS layers were then plasma bonded together and left in an oven at 
75°C overnight to strengthen the bond. Inlet and outlet holes were punched with a 1 mm 
biopsy punch (VWR). 





Clamps used to seal devices were fabricated from acrylic. Sheets of clear, 3 mm 
thick acrylic (McMaster-Carr) were cut with a laser cutter. Clamps were fabricated with 
holes for screws to tighten and holes to allow device tubing connections to pass through 
one side.  
4.2.3 Transport Modeling 
 
COMSOL computational fluid dynamic (CFD) software was used to model 
laminar flow and mass transport within the devices. In all simulations, the 2D steady state 
solution for the incompressible Navier-Stokes equation was first solved for. This solution 
was then used in the 2D steady state model for combined convection and diffusion mass 
transport of a dilute species. Fluid properties were assumed to be those of water. For 
laminar flow, a no slip boundary condition was assumed at all channel walls. The inlet 
velocity was calculated based on the volumetric perfusion rate used. The outlet boundary 
condition was set as an open boundary condition with pressure equal to zero. For mass 
transport, a no flux boundary condition was assumed at all walls. The initial 
concentration and inlet concentration of a species was set as the concentration of that 
species in cell culture media. Finally, to take into account the reaction/consumption of a 
given species by an organoid, this was was described as the flux of that species through a 
2D circular surface, representative of the organoid. 
4.2.4 Forebrain Organoid Culture 
 
Forebrain organoids were formed and cultured according to published protocols
56
. 
EBs were first formed from hiPSC cultures maintained in the Wen lab at University. EBs 
were formed by detaching hiPSC colonies with Collagenase Type IV and were cultured 




Technologies), 20% Knockout Serum Replacement (Life Technologies), 1X Glutamax 
(Life Technologies), 1X non-essential amino acids (Life Technologies), 0.1 mM 2-
mercaptoethanol (Life Technologies), 2 µM A-83 (Tocris), and 2 µM Dorsomorphin 
(Sigma). On days 5-6, half of the media was replaced with induction media containing 
DMEM/F12 (Life Technologies), 1X Glutamax (Life Technologies), 1X non-essential 
amino acids (Life Technologies), 1X Penicillin/Streptomycin (ThermoFisher), 1X N2 
Supplement (ThermoFisher), 1 µM CHIR 99021 (Cellagen  Tech), and 1 µM SB-431542 
(Cellagen Tech). At day 7, organoids were embedded in individual drops of Matrigel 
(Corning) and cultured in induction media in 6-well plates until day 14. At day 14, 
Matrigel was mechanically dissociated from organoids by pipetting with a 5 mL 
serological pipette. Organoids were then transferred to microfluidic devices or low 
attachment tissue culture plates for the remainder of culture. From day 14 on, organoids 
were cultured in differentiation media containing DMEM/F12 (Life Technologies), 1X 
N2 and B27 Supplements (ThermoFisher), 1X Glutamax (Life Technologies), 1X non-
essential amino acids (Life Technologies), 1X Penicillin/Streptomycin (ThermoFisher), 
0.1 mM 2-mercaptoethanol (Life Technologies), and 2.5 µg/mL insulin (Sigma Aldrich). 
For culture in plates, approximately 50 organoids were cultured per plate with 10 mL of 
media. Media was exchanged every other day.  
4.2.5 Organoid Culture in Microfluidic Devices 
 
Prior to each experiment devices, fittings (blunt 16 gauge needles; McMaster-
Carr), and tubing (1/32‖ ID silicone tubing; Cole Parmer) were sterilized by autoclaving. 
The day prior to organoid loading, devices were treated with air plasma to render the 




maintain the hydrophilicity and then re-sterilized with UV light for 30 minutes. Devices 
were then placed in a cell culture incubator overnight. 
Prior to organoid loading, devices were primed with differentiation media. 
Organoids were loaded into individual chambers of the device by pipetting. Following 
loading of organoids into individual chambers, devices were pressed against a sterile 
glass slide (VWR) to seal the chambers and channels. The device and glass slide were 
then placed between two laser cut pieces of acrylic, and screws and nuts were used to 
tighten the entire assembly. Finally, primed tubing and fittings were connected to the 
device inlet and outlet. A 0.2 µm syringe filter was connected at the end of the outlet 
tubing to maintain sterility. Device inlets were connected to syringes and a syringe pump 
(PHD 2000; Harvard Apparatus), and the entire setup was placed in a humidified 
incubator (HERAcell 240i, Thermo Scientific for culture. 
4.2.6 Live Imaging and Quantification 
 
Bright field and phase contrast images of devices were acquired at weekly time 
points during culture using either a dissecting scope or an EVOS microscope. Organoid 
size and eccentricity were quantified from images using manual segmentation in ImageJ.  
4.2.7 Immunohistology, Imaging, and Quantification 
 
Organoids were prepared for immunohistology and imaging as described 
previously.
56
 Organoids were collected from microfluidic devices or tissue culture plates 
and fixed in 4% Paraformaldehyde in PBS for 1 hour at room temperature. Organoids 
were then washed in PBS and incubated in 30% sucrose overnight. Organoids were 
embedded in optimal cutting temperature compound (OCT) and sectioned with a cryostat. 




washed with blocking buffer containing 10% donkey serum and 0.1% Tween-20 in PBS 
for 30 minutes. Next, slices were incubated in primary antibodies in blocking buffer 
overnight at 4°C. Slices were washed with PBS and incubated with secondary antibodies 
in block buffer for 1 hour. Slices there then washed in PBS and incubated with DAPI. 
Images were collected on an epifluorescent microscope. Quantification of imaging data 
was performed both manually and with custom code in the Wen lab.  
4.3 Results and Discussion 
4.3.1 Design of First Generation, Diffusion-Based Microfluidic Device 
The device consists of an array of 30 culture chambers, connected by channels for 
delivering media and reagents (Figure 4.1a). The culture chambers are 5 mm in diameter 
and 5 mm in height, large enough to support the maximum size that forebrain organoids 
reach at 80 days of culture and longer. The media delivery channels connect to the top of 
the culture chambers (Figure 4.1b), so mass transport between the channels and the 
culture chambers is primarily diffusion-based. The value of having the channels connect 
to the top of the chambers is that it enables the device to be fabricated in a single layer. 
The media delivery channels are designed such that all organoids are exposed to the same 
media composition. A large, 0.7mm wide serpentine channel connects all of the 
chambers, and smaller, 0.2 mm wide cross-flow channels connect adjacent columns of 
the device (Figure 4.1a). Transport modeling analysis showed, as will be described in the 
following section, that with this channel configuration organoids were not exposed to 
significantly different concentrations of nutrients or metabolites. Therefore, we deemed 






Figure 4.1. Design of the microfluidic platform for organoid culture. a) Schematic 
illustrates the design of organoid culture device in a top-down view, with inset depicting 
key trap and channel geometries. b) Schematic depicts a side view of a single chamber 
and channels for media delivery. c) Bright field image of chambers with organoids.  
 
Organoids were manually loaded into the individual chambers of devices using a 
pipette (Figure 4.2). Devices were then reversibly sealed to a glass slide using two outer 
pieces of acrylic tightened with screws. Live imaging during culture could be performed 
through the acrylic and glass. The entire device assembly was kept in a standard cell 
culture incubator during culture, and media was delivered at defined rates or frequencies 
using a syringe pump.  
 
Figure 4.2. Device loading and assembly. Schematic depicts a side view of the device. 
Aggregates are loaded into devices with a pipette tip, and then devices are clamped 









Since forebrain organoids grow to millimeters in size, they consume significant 
amounts of nutrients and oxygen and require frequent media changes. In order to 
understand how device operating conditions could be optimized for sufficient delivery of 
nutrients and removal of waste, an approach using computational fluid dynamic (CFD) 
modeling in COMSOL was performed. We modeled conditions within the organoid 
culture device and compared those to conditions in a miniaturized spinning bioreactor, 
the SpinΩ
56
. The SpinΩ consists of a 12-well plate modified to include spinning 
impellers in each well to agitate the media. It is the current state-of-the-art platform for 
culture of forebrain organoids. In choosing what operating conditions to model in the 
organoid culture device, we hypothesized that continuous perfusion of media through the 
device would best support organoid growth. In this design, mass transfer is diffusion-
dominated, so effects of continuous perfusion on removing cell-secreted factors are 
minimal. Overall, the modeling results presented in the following sections should be 
interpreted as general guidelines for ranges of operating conditions that support organoid 






Figure 4.3. Depiction of how one chamber of the device was modeled. The geometry 
reflects a 2D side view of a single chamber with inlet and outlet channels. The organoid 
is modeled as a 2D circle centered at the bottom of the chamber. The heat map shows the 
velocity profile in the chamber for an inlet flow rate of 100 µL/hr. 
 
A 2D cross-section of an individual culture chamber was modeled with a single 
inlet and outlet (Figure 4.3). The organoid was modeled as a circle located at the bottom 
of the culture chamber, and cell secretion and consumption were modeled as flux through 
the perimeter of the circle. We selected a few representative species to model: glucose, 
oxygen, a small molecule media additive, and lactate. Transport properties for each 
species were obtained from literature. Cell consumption and production rates of the 
different species were also obtained from or estimated based on literature. Values for 
each of these and corresponding references are shown in Table 4.1. To estimate the cell 
density within a forebrain organoid for calculating consumption and production rates, we 





value corresponded with our own measurements of cell densities in forebrain organoids at 






























Glucose         17.49         
128,135
 
Oxygen        0.2         
128,136
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4.3.2.2 Glucose Transport and Consumption  
 
In order to assess what media perfusion rate was needed to supply organoids with 
sufficient amounts of nutrients, we modeled transport and consumption of glucose. We 
assessed media flow rates ranging from 25 - 400 μL hr
-1
 and organoid sizes from 0.6 mm 
to 2.0 mm in diameter. These organoid sizes were within the range expected for culture 
time periods of ~40 days or more. As shown in Figure 4.4a, modeling indicates that 
organoids up to 1.6 mm in diameter experience steady state glucose concentrations within 
90% of the initial concentration for all media flow rates modeled. These results indicate 
that relatively low media perfusion rates can be used for organoids up to 1.8 mm in 
diameter. 
 For comparison, glucose consumption in the state of the art culture system for 
forebrain organoids, the SpinΩ bioreactor, was also modeled. To model this geometry, 
we modeled 2 mL of media in a single well of a 12-well plate, assuming it to be well-
mixed. For glucose consumption rates, we assumed there to be 20 organoids in the well. 
Calculating the glucose concentration in the SpinΩ over the 48 hour period between 




the initial concentration by 24 hours for organoids that are 1.6 mm in diameter or larger. 
These modeling results indicate that organoids in the SpinΩ (and likely in similar culture 
formats) see large variances in glucose concentration between media changes, 
particularly for organoids 1.6 mm and larger. Remaining within 90% of the initial 
concentration is therefore perhaps an overly stringent requirement for the microfluidic 
platform. Additionally, these results suggest that microfluidic culture has the potential to 
maintain better consistency in nutrient concentrations over culture periods.  
 
 
Figure 4.4. Glucose transport and consumption. a) Graph shows average glucose 
concentration at organoid surface for a range of organoid sizes and media perfusion rates. 
b) Graph shows the change in average glucose concentration in one well of the SpinΩ 
bioreactor over a 48-hour period for a range of organoid sizes. 
4.3.2.3 Oxygen Transport and Consumption 
 
We next modeled transport and consumption of oxygen in the microfluidic 
device. PDMS is oxygen permeable, so diffusion of oxygen through the PDMS was 
considered. The geometry of the CFD model in COMSOL was altered to consider oxygen 
transport in the PDMS, as shown in Figure 4.5a. A single column of the device, with five 
culture chambers in series was modeled. The device is clamped to glass with an acrylic 




atmosphere were the left and right edges. Results from the center chamber are reported 
here, as the ―worst case scenario‖ of oxygen concentration, since that chamber is the 
farthest from the edges of PDMS exposed to the atmosphere. For modeling oxygen 
transport in the SpinΩ bioreactor, diffusion of oxygen from air to the media was 
considered. The well of the bioreactor was assumed to be well-mixed. 
Results from modeling oxygen transport and consumption for the center chamber, 
as shown in (Figure 4.5b), indicate that organoids experience oxygen concentrations 
below 90% of atmospheric oxygen for all perfusion rates modeled. In particular, the 
modeling results suggest that organoids greater than 1.4 mm completely deplete oxygen 
at their surface. It is important to note that organoids approximately 1.0 mm in diameter 
and smaller do experience oxygen concentrations above what is considered hypoxic 
conditions (5% oxygen, equivalent to 0.065 mol m
-3
) for perfusion rates of 100 μL hr
-1
 
and higher. Many reports in literature suggest that hypoxic conditions are preferential for 
culture of many cell types
139-141
 including stem cells. Therefore oxygen conditions 
experience by smaller organoids (< 1.0 mm) may be sufficient for supporting growth and 
differentiation. In comparison, in the SpinΩ organoids all experience oxygen 
concentrations below 90% of the initial value (Figure 4.5c). However, oxygen 
concentrations remain relatively constant between media exchanges after an initial 
decrease, and organoids up to 1.8 mm do not experience conditions below what is 
considered hypoxia. 
Overall, these results suggest that oxygen is potentially a limiting nutrient in the 
microfluidic culture platform, and organoids may experience hypoxic conditions. It is 




organoid geometry is assumed to be that of an infinite cylinder in the model. In the 
future, 3D CFD models could be used to reduce this over-estimation. Nevertheless, these 
results suggest that potential effects of oxygen limitations on organoid phenotypes need 
to be monitored. Various strategies could also be used to increase oxygen delivery in the 
device. One method to increase oxygen delivery would be to dissolve a higher 
concentration of oxygen in the media before infusion into the device.  
 
 
Figure 4.5. Modeling oxygen transport and consumption. a) Geometry used to model 
oxygen transport and consumption in the first generation microfluidic device. The heat 
map shows the velocity profile for a flow rate of 100 µL/hr. b) Graph shows average 
oxygen concentration at organoid surface in the center of five chambers in series for a 
range of organoid sizes and media perfusion rates. c) Graph shows the change in average 
oxygen concentration in one well of the SpinΩ bioreactor over a 48-hour period for a 
range of organoid sizes. 





We next assessed transport and consumption of a small molecule media additives. 
Small molecules are typically added to media to activate or inhibit signaling pathways to 
promote differentiation. Examples of small molecules used in the forebrain organoid 
differentiation protocols include CHIR 99021, as glycogen synthase kinase 3beta 
(GSK3β) inhibitor, and SB-431542, a transforming growth factor beta (TGFβ) pathway 
inhibitor. The same approach as used for glucose was used for modeling transport and 
consumption of a small molecule. For all perfusion rates and organoid sizes modeled, 
organoids in the microfluidic device experience within 90% of the inlet concentration of 
a representative small molecule (Figure 4.6a). In comparison, in the SpinΩ, the 
concentration drops below 90% of the inlet concentration for 1.6 mm and 2.0 mm 
organoids towards the end of each media exchange (Figure 4.6b). These results indicate 
that microfluidic perfusion at a range of rates is sufficient for delivery small molecules to 
the organoids, and that microfluidic perfusion can be used to maintain more temporally 








Figure 4.6. Small molecule transport and consumption. a) Graph shows average small 
molecule concentration at organoid surface for a range of organoid sizes and media 
perfusion rates. b) Graph shows the change in average small molecule concentration in 
one well of the SpinΩ bioreactor over a 48-hour period for a range of organoid sizes.  
4.3.2.5 Lactate Transport and Secretion 
 
Lactate is one type of metabolic waste produced by cells, so we next assessed 
whether microfluidic perfusion could adequately remove lactate from the culture 
chambers. We modeled lactate transport and secretion as with the other types of 
molecules assessed, but with a cellular production term instead of consumption. In 
microfluidic devices, steady state lactate concentrations range from 300 – 400 mol m
-3
 for 
2.0 mm aggregates (Figure 4.7a). In comparison, in the SpinΩ lactate levels can reach as 
high as 700 mol m
-3 
by 48 hours after a media exchange (Figure 4.7b). Based on the 
comparison of maximum lactate levels in the device versus SpinΩ culture, we concluded 
that microfluidic perfusion sufficiently removes lactate. 
 
 
Figure 4.7. Lactate transport and secretion. a) Graph shows average lactate concentration 
at organoid surface for a range of organoid sizes and media perfusion rates. b) Graph 
shows the change in average lactate concentration in one well of the SpinΩ bioreactor 




4.3.2.6 Differences in Species Concentrations Among Culture Chambers 
 
One element of the first generation organoid culture device design is that media 
passes serially through the culture chambers. The implication of this is that organoids 
downstream in the device could potentially experience lower concentrations of molecules 
that are consumed and higher concentrations of molecules that are secreted. To assess 
this, the 30 chambers of the device were modeled in series. We made the assumption that 
media only flowed through the main serpentine channel. This assumption describes the 
worst case scenario: while the majority of the volumetric flow travels through the main 
serpentine channel, a small portion travels through the narrow channels between adjacent 
columns in the device. Based on this model, we assessed the average concentration of 
glucose, a small molecule, and lactate in each of the 30 culture chambers of the device. In 
Figure 4.8, the concentrations of these species at the organoid surface, in the entire 
chamber, and at the chamber outlet are shown for a 1.6 mm organoid and a 200 μL hr
-1
 
flow rate. For glucose and a small molecule, the concentration difference between the 
first and last chamber is less than 10%. For lactate, the maximum concentration reached, 
in chamber 30, is still well below what organoids experience in the SpinΩ. Based on 
these results, we conclude that variations of concentrations of nutrients, small molecules, 






Figure 4.8. Differences in glucose, small molecule, and lactate concentrations among 
culture chambers. Graphs show the modeled average (a) glucose, (b) small molecule, and 
(c) lactate concentrations at the organoid surface, within the chamber, and at the chamber 
outlet for every chamber in a given device. These were modeled for a 1.6 mm diameter 
organoid and a 200 μL hr
-1
 media perfusion rate. 
 
4.3.3 Testing Organoid Culture in First Generation Device Design 
4.3.3.1 Overview 
 
In order to test use of the microfluidic device for forebrain organoid culture, day 
14 organoids were loaded into devices and cultured under continuous perfusion at 200 μL 
hr
-1
. Day 14 was chosen for beginning microfluidic culture, as it is the point in the culture 
protocol at which organoids are removed from individual beads of Matrigel. The 
perfusion rate of 200 μL hr
-1
 was chosen based on results from the transport modeling 
analysis that indicated that further increasing the flow rate resulted in only small changes 
in concentrations of nutrients, small molecules, and metabolites. Additionally, there is a 
tradeoff in that higher perfusion rates use larger volumes of expensive media. As a 




media). For some time points, organoids cultured in a SpinΩ bioreactor in the Wen lab at 
Emory University were also available for comparison.  
4.3.3.2 Organoid Size and Gross Morphology 
 
In order to assess organoid development, size and gross morphology were 
assessed from bright field images acquired at weekly time points. Figure 4.9 shows the 
same two representative organoids at each time point in microfluidic devices and 
different representative organoids at each time point in tissue culture plate controls. 
Organoids appeared to grow normally in devices: they displayed expected size increases, 
maintained a round morphology, and exhibited expected morphological features. In 
particular, organoids exhibited neural epithelium/neural tube-like structures that are a key 
feature of forebrain organoids
56
 (Figure 4.9c). Heterogeneity was observed in terms of 
organoid size and morphology both in devices and in tissue culture plate controls, and 






Figure 4.9. Representative bright field images of forebrain organoids. a) Images of two 
representative forebrain organoids culture in devices. b) Images of different 
representative forebrain organoids culture in tissue culture plates. c) Image of a D28 
organoid cultured in device with round, neuroepithelial structures faintly visible and 
outlined in yellow. All scale bars: 100 µm. 
 
 In order to assess growth, organoid diameter was quantified. The cross-sectional 
area was measured from bright field images and then used to calculate an equivalent 




culture. Organoids cultured in devices were, on average, slightly smaller than plate 
controls at days 21, 28, and 35, although this difference was only statistically significant 
at days 28 and 35. Organoid circularity was also assessed, with a value of 1 representing 
a perfect circle (Figure 4.10b). Organoids across all conditions tended to be round, and 
there were no statistically significant differences between days or conditions. Growth rate 
was also calculated by quantifying the difference in size between two time points and 
normalizing the by the size at the first of the two time points (Figure 4.10c). Plate 
controls showed a higher growth rate at days 21 and 28 compared to organoids cultured 
in devices, but by day 35 there was little difference in growth rate. Together, based on 
size, morphology, and growth rate assessments, these results indicated that organoids 
cultured in devices developed similarly to plate controls, but with some reduction in size 
and growth. The size difference could be due to reduced cellular proliferation or 






Figure 4.10. Organoid size, morphology, and growth rate. a) Organoid diameter 
measured at days 14, 21, 28, and 35 of culture. Diameter was calculated from the cross-
sectional area of organoids in brightfield images. Two-way ANOVA with Bonferroni 
posttests was used; * indicates p < 0.01. b) Organoid circularity at days 14, 21, 28, and 35 
of culture was calculated from brightfield images. Two-way ANOVA with Bonferroni 
posttests was used; all samples n.s. c) Growth rate was calculated, defined as the 
difference in size between two time points and normalized by the size at the first of the 
two time points. Two-way ANOVA with Bonferroni posttests was used for devices only, 
as plate control growth rate was calculated from population averages. For all graphs, 
error bars indicate SEM. 
 
 We investigated whether there was any correlation between location in the device 
and organoid size, even though transport modeling results suggested that different types 
of molecules had minimal concentration differences across the device. Figure 4.11 shows 
organoid diameter plotted as a function of culture chamber number for 7 different devices 
from 4 independent experiments. Numbering denotes position along the main serpentine 
channel with chamber 1 at the device inlet and chamber 30 at the device outlet. Based on 
the Spearman correlation coefficient, there was no correlation between size and position. 
This further supports the assertion that perfusion of the media serially through the culture 






Figure 4.11. Organoid size as a function of position in the device at D35. Diameters of 
day 35 forebrain organoids from 7 devices from 4 independent experiments are shown, 
with each device indicated by a different symbol. Numbering denotes position along the 
main serpentine channel with chamber 1 at the device inlet and chamber 30 at the device 
outlet. 
4.3.3.3 Immunohistological Characterization of Forebrain Organoids 
 
We next characterized organoids by immunohistological analysis to assess if cell 
types and structural features characteristic of forebrain organoids were present. All 
immunohistology, imaging, and image analysis steps were performed by collaborators in 
Dr. Zhexing Wen’s lab at Emory University. We first assessed the generation and 
proliferation of neural progenitor cells (NPCs) at days 21, 35, and 42. At all time points, 
organoids cultured in microfluidic devices exhibited polarized neuroepithelium-like 
structures resembling neural tubes containing SOX2+ NPCs (Figure 4.12). SOX2+ 
neural tube structures were also observed in plate controls at all time points and in SpinΩ 
cultures at day 42 (the one time point that samples were available for assessment). 
Interestingly, organoids cultured in plates appeared be less differentiated evidenced by 
the larger, less complex neural tube structures visible at day 21 and as late as day 42 




smaller neural tube structures more integrated with surrounding cells, which is indicative 
of more mature forebrain organoid structures. 
 
Figure 4.12. Characterization of cellular proliferation. Immunohistological analysis was 
performed for (a) day 21, (b) day 35, and (c) day 42 forebrain organoids cultured in 
devices, plate controls, or the SpinΩ bioreactor. Representative images show staining for 




100 µm. Images are representative of 20-40 organoids per time point. 3 independent 
experiments for day 21, 4 independent experiments for day 35, one experiment for day 
42.  
 
As organoids mature, dividing SOX2+ NPCs start to exit the cell cycle. Ki67 
staining at days 21, 35, and 42 indicated that some but not all SOX2+ cells in device 
organoids were mitotic (Figure 4.12). In contrast, in plate controls, a larger proportion of 
SOX2+ cells were still Ki67+. These observations were confirmed by quantification of 
the proportion of SOX2+ cells that were also Ki67+, as shown in Figure 4.13. Organoids 
cultured in devices had lower proportions of dividing NPCs at days 21, 35, and 42, 
indicating that they were more differentiated than plate controls. 
 
Figure 4.13. Quantification of proliferation of NPCs. The percentage of proliferating 
(Ki67+) NPCs (SOX2+) was quantified from immunohistology images. Data is shown 
for device and plate cultures at days 21, 35, and 42. Error bars indicate S.D. ANOVA was 
used; ** indicates p < 0.001; *** indicates p < 0.0001. Data is representative of 20-40 
organoids per time point. 3 independent experiments for day 21, 4 independent 
experiments for day 35, one experiment for day 42. 
 
 Next, we examined differentiation of forebrain organoids by assessing expression 
of cortical plate layer (CP) markers TBR1 and MAP2 in addition to NPC/ventricular zone 




layer stratified neural tube like structures with TBR1+/MAP2+ CP structures surrounding 
SOX2+ VZ structures at all three time points assessed (Figure 4.14). These structures 
were also robustly observed in SpinΩ cultures at the day 35 time point that was assessed 
(Figure 4.14b). In contrast, organoids cultured in plates at day 21 had not yet developed 
TBR1+/MAP2+ CP layers (Figure 4.14a). These structures were not observed until day 
35 and were also seen at day 42. (Figure 4.14b,c). To quantify these observations, the 
relative thicknesses of the VZ and CP layers were measured from images of organoids at 
days 21, 35, and 42. Yellow outlines in the merged images in Figure 4.14b shows how 
the regions were defined and measured. The two graphs in Figure 4.15 plot the relative 
layer thickness of TBR1+ CP to SOX2+ VZ at days 21, 25, and 42. Forebrain organoids 
cultured both in devices and plate controls had increasing CP layer thicknesses over the 
three time points assessed, as expected. Additionally, device organoids had thicker CP 








Figure 4.14. Characterization of forebrain organoid differentiation. Immunohistological 
analysis was performed for (a) day 21, (b) day 35, and (c) day 42 forebrain organoids 
cultured in devices, plate controls, or the SpinΩ bioreactor. Representative images show 
staining for NPCs (SOX2), cortical plate layer markers (TBR1, MAP2) and cell nuclei 
(DAPI). All scale bars are 100 µm. Images are representative of 20-40 organoids per time 
point. 3 independent experiments for day 21, 4 independent experiments for day 35, one 







Figure 4.15. Quantification of VZ and CP layer thickness. The relative thicknesses of VZ 
(SOX2+) and CP (TBR1+) layers were quantified from immunohistology images. Data is 
shown for (a) device and (b) plate cultures at days 21, 35, and 42. Error bars indicate S.D. 
Data is representative of 20-40 organoids per time point. 3 independent experiments for 
day 21, 4 independent experiments for day 35, one experiment for day 42.  
 
We next examined cell death in forebrain organoids through assessment of both 
bright field images and caspase-3 (CASP3) staining. Organoids were assessed by bright 
field microscopy at days 21, 35, and 42 and manually categorized as ―intact‖, indicating 
that they were structurally intact, or ―non-intact‖, indicating that there were large 
amounts of cell death causing the overall organoid structure to disintegrate. A subset of 
organoids both in devices and plate controls were characterized as non-intact and 
displayed large amounts of cell death. There was a slightly larger percentage of ―intact‖ 
organoids in plate controls compared to devices (n.s., Figure 4.17a). For the intact 
organoids in devices and plate controls, cell death was assessed by CASP3 staining at 
days 21, 35, and 42. Small numbers of CASP3+ cells were observed in both device and 
plate control at all time points (Figure 4.16). Quantification of the percentage of 
CASP3+ cells in relation to the total number of cells (DAPI+) confirmed that all 




increased proportions of CASP3+ cells compared to plate controls, but this difference 





Figure 4.16. Characterization of cell death within forebrain organoids. 
Immunohistological analysis was performed for (a) day 21, (b) day 35, and (c) day 42 
forebrain organoids cultured in devices or plate controls. Representative images show 
staining for NPCs (SOX2), the cell death marker caspase-3 (CASP3), a CP layer marker 




20-40 organoids per time point. 3 independent experiments for day 21, 4 independent 
experiments for day 35, one experiment for day 42. 
 
 
Figure 4.17. Quantification of cell death in organoids. a) The percentage of organoids 
with intact overall structure was manually quantified from bright field images for 
organoids cultured in devices and plate controls at days 21, 35, and 42. b) The percentage 
of dead cells (CASP3+) was quantified from immunohistology images for devices and 
plate controls at days 21, 35, and 42. Error bars indicate S.D. ANOVA was used; all 
groups: n.s. Data is representative of 20-40 organoids per time point. 3 independent 




Characterization of forebrain organoids cultured in the first generation 
microfluidic device revealed that organoids developed as expected in terms of generating 
stratified neural tube like structures with a VZ composed of SOX2+ NPCs and a CP layer 
with TBR1+/MAP2+ cells. At day 35, these structures were similar between organoids 
cultured in devices versus in a SpinΩ bioreactor. Interestingly, organoids cultured in 
devices were less heterogeneous and more differentiated than organoids observed in 
static plate cultures. Organoids cultured in plates had simpler, less differentiated neural 
tube structures, particularly at the day 21 time point. Previous work has shown that 
agitating the culture media can result in better organoid differentiation due to mixing-
facilitated nutrient  delivery
56
, and this is a possible explanation for the less differentiated 




microfluidic platform supports generation of forebrain organoids with cell types and 
structures comparable to what has been demonstrated in previous work.  
We did observe that organoids cultured in devices tended to be smaller and had 
increased cell death. The specific cause of this is unclear, but it could be due to nutrient 
and/or oxygen limitations. In this first generation microfluidic design, media exchange is 
diffusion-dominated because the media perfusion channels are located above each culture 
chamber. Although this design enables the device to fabricated in a single layer, it results 
in less efficient media exchange in each culture chamber. The largest organoid diameter 
reached in device cultures was ~ 1.1 mm. Based on the transport modeling analysis 
described in Section 4.3.2, organoids of this size were likely not nutrient-limited for a 
nutrient such as glucose but may have experienced lower oxygen concentrations. To 
address any possible issues with nutrient/oxygen delivery, in the next portion of this 
chapter, we explored modifying the device design to enable better media exchange in the 
culture chambers.  
4.3.4 Design of Second Generation, Flow-Through Microfluidic Device 
 
Following design and testing of the first generation, diffusion-based device for 
forebrain organoid culture, a number of improvements were identified and implemented 
in a second generation device design (Figure 4.18). First, the media delivery channel 
configuration was re-designed to provide each culture chamber with a separate inlet and 
outlet (Figure 4.18a). This allows each culture chamber to be perfused with media in 
parallel—e.g. media does not flow serially from one chamber to the other, as with the 
first device design. Media is perfused from a single inlet in this design, and bifurcating 




easily modified by reconfiguration the inlet and bifurcating channels so that each column 
of the device can be perfused with different media compositions. A key modification in 
this is design is the method by which media is exchanged in each culture chamber. As 
shown in the perspective view in Figure 4.18b, there is convective flow of media through 
each culture chamber through an inlet channel at the top of the chamber and an outlet 
channel at the bottom. This design better exchanges fluid in the culture chambers, 
compared to the previous, diffusion-dominated device design. A final change was to alter 
the culture chamber spacing so that it conforms to a 96-well plate footprint. This makes 




Figure 4.18. Design of the second generation, flow-through microfluidic device for 
organoid culture. a) Schematic illustrates the design of both device layers in a top-down 
view. b) Schematic depicts enlarged top view and perspective views of a single chamber 
with key dimensions noted. 
 
The microfluidic platform is assembled similarly to the first generation design , as 
shown in Figure 4.19. The two device layers are fabricated from PDMS and bonded 




into the device, and the device is then reversibly sealed to a glass slide using acrylic 
clamps and screws.  
 
 
Figure 4.19. Assembly of the device. Schematic shows each of the device layers and 
order of assembly. 
4.3.5 Transport Modeling in Second Generation Device Design to Inform 
Optimization of Operating Conditions 
 
As with the first device design, we performed CFD modeling to assess how 
device operating conditions would impact delivery of nutrients and small molecules and 
removal of metabolites. We expected this through-flow chamber design to be more 
effective at exchanging media in each chamber because of the presence of convective 
flow. Transport modeling indicated that the previous device design adequately 
maintained concentrations of small molecules and removed metabolites such as lactate 
across a range of organoid sizes and operating conditions (Sections 4.3.2.4 and 4.3.2.5). 
Therefore, for the purpose of identifying appropriate operating conditions for this design, 




As before, a 2D cross-section of an individual culture chamber was modeled with 
a single inlet and outlet, with the organoid represented as a circle centered in the chamber 
(Figure 4.20). All transport properties, concentrations, production/consumption rates, 
and cell densities used were the same as those used previously. Modeling results for the 
organoid culture device were again compared to those modeled for the SpinΩ. 
 
Figure 4.20. Depiction of how one chamber of the device was modeled. The geometry 
reflects a 2D side view of a single chamber with inlet and outlet channels. The organoid 
is modeled as a 2D circle centered at the bottom of the chamber. The heat map shows the 
velocity profile in the chamber for an inlet flow rate of 100 µL/hr. 
 
 We first assessed what media perfusion rate was needed to supply organoids with 
sufficient amounts of glucose. We modeled continuous media flow rates ranging from 50 
- 400 μL hr
-1
 and organoid sizes from 0.6 mm to 2.6 mm in diameter. Although organoids 
typically only reached ~1.3 mm in diameter by day 35 in plate controls (Figure 4.10a), 
we wanted to assess if devices could also be used for longer culture times with larger 
organoids. As shown in Figure 4.21, for media perfusion rates of 200 μL hr
-1
 and higher, 
organoids up to 2.6 mm in diameter experienced glucose concentrations within 90% of 
the initial concentration. This reflected an improvement over the initial, diffusion-based 
device design, in which media perfusion at 200 μL hr
-1 
could maintain glucose 




smaller (Figure 4.4a). Overall, these results indicate that this device design delivers a 
nutrient such as glucose more efficiently and that glucose is not likely a limiting nutrient 
for organoids up to 2.6 mm.   
 
Figure 4.21. Glucose transport and consumption. a) Graph shows average glucose 
concentration at organoid surface for a range of organoid sizes and media perfusion rates.   
 
 We next modeled oxygen transport and consumption in the device. A similar 
geometry as before was specified for the model, with a column of seven chambers 
modeled and diffusion of oxygen through the PDMS taken into account (Figure 4.22a). 
Results from the center chamber are reported here to represent the ―worst case scenario‖ 
of oxygen concentrations. Figure 4.22b shows the average oxygen concentration at the 
organoid surface in the center chamber for a range of organoid sizes and media perfusion 
rates. The modeling results show that oxygen concentrations fall below 90% of the initial 
concentration for all flow rates and organoid sizes modeled. Organoids approximately 1.4 
mm in diameter and smaller experience hypoxic conditions (5% oxygen, equivalent to 
0.065 mol m
-3
) for perfusion rates of 200 μL hr
-1




minimal effect on increasing the oxygen concentration at steady state. Overall, these 
modeling results show improvement over the previous design, in which a maximum 
organoid size of 1.0 mm experience hypoxic oxygen concentrations or greater.  
As discussed previously, oxygen consumption may be over-estimated in this 2D 
model because the organoid geometry is assumed to be an infinite cylinder. However, 
these results suggest that oxygen is potentially a limiting nutrient. Future work is needed 
to assess if potentially hypoxic conditions in devices have undesired effects on organoid 
growth and differentiation. In our studies, we did not implement additional design or 
experimental protocol changes to increase oxygen delivery, but this is a parameter that 





Figure 4.22. Modeling oxygen transport and consumption. a) Geometry used to model 
oxygen transport and consumption. Heat map shows the velocity profile for a flow rate of 
100 µL/hr. b) Graph shows average oxygen concentration at organoid surface in the 
center of seven chambers in series for a range of organoid sizes and media perfusion 
rates. 
4.3.6 Testing Organoid Culture in the Second Generation Device Design 
4.3.6.1 Overview 
 
In order to test the use of the second generation microfluidic device for forebrain 
organoid culture, day 14 organoids were cultured in devices up to day 35. It was expected 
that organoids would remain viable and develop normally, based on results obtained in 
the first device design. However, it was anticipated that there could be subtle differences 
in organoid growth and phenotypes as a result of the design changes affecting media 




characterization of organoid growth and gross morphology only. Future work will be 
needed to assess cell types and structural features of organoids to confirm that they 
develop normally in the devices. 
For testing of the devices, two different media exchange conditions were chosen. 
In the first condition, organoids were cultured with continuous perfusion at 200 μL hr
-1
. 
This perfusion rate maintained glucose concentrations within 90% of the initial 
concentration for a large range of organoid sizes (up to 2.6 mm; Figure 4.21), and 
increasing the flow rate above this did not significantly increase steady state oxygen 
concentrations (Figure 4.22b).   
The second condition chosen was culture of organoids under static media 
conditions with exchange of media once every 24 hours (24 hr
-1
). A discontinuous media 
perfusion condition was chosen to help assess if continuous perfusion had any negative 
effects on organoid development. Continuous perfusion is known to down-regulate 
autocrine/paracrine signaling, as extensively discussed in Chapter 3 of this thesis. We 
hypothesized that this might be less of a concern for organoids than for smaller cell 
aggregates; the rationale was that the larger size and higher cell numbers of organoids 
could be better able to maintain cell-signaling environments within organoids. 
Nevertheless, we thought it prudent to include a static media control. The media 
exchange frequency of 24 hours was chosen based on a comparison to the volume of 
media per organoid and media exchange frequency used in SpinΩ culture. SpinΩ culture 
and the microfluidic device operate with the same volume of media per organoid: 2 mL 




exchanged in the SpinΩ every 48 hours, so as a conservative estimate, we chose to 
exchange media in devices every 24 hours.  
4.3.6.2 Organoid Size and Morphology 
 
In order to evaluate organoid development, size and gross morphology were 
assessed from bright field images acquired at weekly time points. Figure 4.23 shows 
representative images of organoids at days 14, 21, 28, and 35 for both microfluidic 
culture conditions (24 hr
-1
 and 200 μL hr
-1
) and static plate controls. The same organoid 
is shown at each time point in devices, whereas different organoids are shown at each 
time point for plate controls. Overall, organoids appeared to grow normally in devices 
with expected size increases, maintenance of round morphologies, and expected 
morphological features visible. Neural epithelium/neural tube like structures were 
observed in organoids cultured in all three conditions, characterized by the round rosette- 
or bud-like morphologies features in the representative images (Figure 4.23). Some cell 
death was observed in both microfluidic culture conditions starting at day 21. This was 
characterized by dead cells separating from the main organoid structure. Interestingly, the 
majority of organoids with large amounts of dead cells present in the culture chamber still 





Figure 4.23. Representative bright field images of forebrain organoids. a) Images of 
representative forebrain organoids cultured in devices or static plate controls at days 14, 
21, 28, and 35. Devices were operated with media exchange every 24 hours (24 hr
-1
) or 
continuous perfusion at 200 μL hr
-1
. All scale bars: 100 µm. 
 
 We quantified organoid size, circularity, and growth rate for both microfluidic 
device conditions and plate controls. As shown in Figure 4.24a, organoids increased in 
size over 35 days of culture. Organoids cultured at 200 μL hr
-1
 were slightly large in size 
than plate controls at all time points, but this difference was not statistically significant. 
In comparison, organoids cultured at 24 hr
-1
 were similar in size to the other conditions at 
days 14 and 21 but were significantly smaller than 200 μL hr
-1
 devices and plate controls 
at days 28 and 35. These results suggest that the 200 μL hr
-1
 device condition supports 
growth similar to plate controls. Slightly smaller organoid sizes for the 24 hr
-1
 device 
condition may suggest that this media exchange frequency is not sufficient. Organoid 
circularity was also assessed, as shown in Figure 4.24b. There were subtle differences in 
organoid circularity at days 14, 21, and 28, but these differences were not statistically 




between two time points and normalizing the by the size at the first of the two time points 
(Figure 4.24c). Organoids cultured at 200 μL hr
-1
 had a reduced growth rate compared to 
plate controls at days 14 and 21 but had a slightly higher growth rate at day 35. 
Organoids cultured at 24 hr
-1
 had similar growth rates to 200 μL hr
-1
 devices at days 21 
and 25 but, interestingly had a lower growth rate at day 28. Together, this data suggests 
that of the two microfluidic culture conditions tested, continuous perfusion at 200 μL hr
-1 
may better support organoid growth. Exchanging media once per day may not sufficient 
for delivering nutrients. Additionally, there were subtle differences in organoid size and 
growth rate between microfluidic cultures at 200 μL hr
-1 
perfusion and plate controls. 
 
Figure 4.24. Organoid size, morphology, and growth rate. a) Organoid diameter 
measured at days 14, 21, 28, and 35 of culture. Diameter was calculated from the cross-
sectional area of organoids in bright field images. Two-way ANOVA with Bonferroni 
posttests was used; * indicates p < 0.01. b) Organoid circularity at days 14, 21, 28, and 35 
of culture was calculated from bright field images. Two-way ANOVA with Bonferroni 
posttests was used; * indicates p < 0.01. c) Growth rate was calculated, defined as the 
difference in size between two time points and normalized by the size at the first of the 
two time points. Two-way ANOVA with Bonferroni posttests was used for devices only, 
as plate control growth rate was calculated from population averages. * indicates p < 






Assessments of organoid size and morphology over 35 days of culture in the 
second generation device design suggested that organoids develop normally in devices. 
Although some amounts of cell death were observed, organoids maintained intact 
structures and grew larger in this design by day 35 (average diameter ~ 1.4 mm) 
compared to the previous design (average diameter ~ 1.1 mm). Detailed characterization 
of organoid cell types and structures is still needed to fully validate this device design and 
culture conditions. However, the results described here provide preliminary evidence that 
this device design supports culture of forebrain organoids. Forebrain organoid features 
such as neural tube like structures were present in organoids culture both in devices and 
plate controls. In future work, immunohistological analysis can be used to evaluate the 
presence of a VZ layer containing SOX2+ NPCs and a CP layer containing TBR1+ and 
MAP2+ cells within these structures. Additionally, further analysis of cell death, for 
example with CASP-3 staining, will help assess how microfluidic culture conditions can 
be optimized to increase cell viability. 
4.4 Conclusions 
In this chapter, I designed and validated two versions of a microfluidic platform 
for culture and analysis of forebrain organoids. The microfluidic platform addresses 
current challenges associated with multiplexing and scaling of current organoid culture 
systems. It also provides the ability to observe and assess organoids throughout culture, 
enabling the collection of information that can be used to better understand parameters 
governing forebrain organoid development and assessing different organoid features 




quantitative transport modeling analysis was used to assess how microfluidic culture 
conditions impact delivery and removal of key nutrients, media additives, and 
metabolites. This analysis provides a framework for understanding how to optimize 
device geometries and media exchange conditions.  
Forebrain organoid development was validated in the first generation, diffusion-
based microfluidic platform through morphological and immunohistological assessments. 
Importantly, the results of these analyses demonstrated that forebrain organoids 
developed as expected, with cell types and structures comparable to those obtained in a 
SpinΩ bioreactor for culture times up to 42 days. Interestingly, organoids cultured in 
microfluidic devices were more differentiated with better defined VZ and CP layers than 
organoids cultured in static media in tissue culture plates. This suggests that microfluidic 
perfusion culture can replicate effects of a miniaturized spinning bioreactor in supporting 
forebrain organoid differentiation.  
Following validation of forebrain organoid culture in the initial device, we 
implemented design improvements in a second generation, flow-through microfluidic 
device design. This design is based on a 96 well plate footprint and can easily be 
modified and scaled up to screen multiple conditions in a single device. We validated 
forebrain organoid culture in this version of the design by characterizing organoid size 
and morphology. Organoids grew slightly larger in this design than previously, likely due 
to improved delivery of nutrients and removal of waste with the new channel design. 
While full characterization is still needed of forebrain organoid cell types and structures 





Overall, the work performed in this chapter establishes a novel microfluidic 
platform for culture of forebrain organoids. This platform technology will serve as a 
valuable tool for understanding how to more robustly generate forebrain organoids, 
studying developmental disorders, and performing drug screening. Additionally, this 
technology can be applied to other organoid types. Further opportunities for development 









5.1 Thesis Contributions 
 
The overall objective of this thesis was to develop microfluidics-based 
technologies for culture and assessments of PSC aggregates. The work presented here 
addresses technological gaps associated with current conventional and microfluidic 
culture systems: namely, the lack of ability to culture and assess individual aggregates 
without sacrificing throughput, experimental ease, or imaging capabilities. The 
microfluidics-based technologies developed in this thesis enable collection of single-
aggregate and single-cell level phenotypic information. The ability to observe individual 
samples at multiple time points is highly informative for studying stem cell 
differentiation and tissue morphogenesis, particularly with the use of reporter cell lines. 
This work incorporated interdisciplinary knowledge and techniques. Microfabrication 
methods, computational fluid modeling, and qualitative transport modeling analyses were 
used to design the microfluidic platforms and optimize operating conditions. To collect 
and quantify cellular phenotypic information, techniques including 
immunocytochemistry, microscopy, and image processing were used.  
The microfluidic platforms described in this thesis allow for culture of stem cell 
aggregates at two size scales: ~200 - 500 μm diameter (Chapters 2 and 3) and ~0.6 - 5 
mm diameter (Chapter 4). Both sets of platforms enable culture of individual aggregates 
and imaging-based assessments during culture. Although these technologies were 
developed and validated specifically for mESC aggregates and iPSC-derived forebrain 




aggregates. Examples include tumor spheroids, other stem cell aggregates types, and 
other organoid types.  
In Chapters 3 and 4, computational and qualitative transport modeling were used 
to optimize microfluidic media exchange conditions. The microscale culture environment 
varies from that of macroscale culture in many critical aspects, such as the density of 
cells per media volume and the relative roles played by convective and diffusive mass 
transport. Thus, modeling-based approaches were important in understanding how to 
design microfluidic culture conditions to support cell growth and differentiation. The 
work in Chapter 3 explored how to design media exchange strategies to balance 
requirements for nutrient delivery with the need to maintain concentrations of cell-
secreted factors. This was shown in the context of motor neuron differentiation of mESC 
aggregates. Results indicated that discontinuous media perfusion better supported 
differentiation by allowing accumulation of cell-secreted factors required for cellular 
processes associated with growth and differentiation. In Chapter 4, in the context of 
forebrain organoid culture, transport modeling enabled identification of ranges of 
operating conditions that would support organoid growth and survival. Selected 
conditions were then validated experimentally by characterization of organoid growth, 
morphology, cell types, and structures at up to 8 weeks of culture.  
Throughout this thesis, microfluidic techniques were leveraged to control and 
perturb cell and aggregate phenotypes. The work in Chapter 3 demonstrated that 
microfluidic culture could be used to perturb the cell microenvironment in ways that 
conventional batch culture methods could not. Specifically, this work showed how 




soluble factors and influence spatial patterns of pMN differentiation. This effect was 
dependent on media perfusion frequency. This finding has implications for applications 
in spatial patterning of tissues and understanding how symmetry-breaking events occur 
during embryonic development. In Chapter 4, long-term microfluidic culture was shown 
to produce forebrain organoids comparable to those generated with state-of-the-art 
methods, in terms of morphology, cell types, and structural features. Interestingly, 
forebrain organoids cultured in microfluidic devices were more differentiated with better 
defined VZ and CP layers than organoids cultured in static media in plates, but were 
comparable to organoids cultured in the SpinΩ bioreactor. This suggests that microfluidic 
perfusion culture can replicate effects of a miniaturized spinning bioreactor in supporting 
better organoid differentiation.  
Overall, the technologies developed in this thesis provide new capabilities for 
culture, manipulation, and assessment of PSC-derived tissues ranging in size from small 
aggregates to large organoid tissues. I envision that these tools can be broadly applied by 
our lab and others for studying mechanisms of stem cell differentiation and tissue 
morphogenesis. Specifically for PSC-derived organoids, the tools we have developed will 
enable studies in learning how to more robustly generate forebrain organoids, studying 
developmental disorders, and performing drug screening.  
 
5.2 Future Directions 
 
The microfluidic platforms developed in this thesis facilitate culture and 
assessment of different types of 3D stem cell derived tissues.  In this section, I discuss 




5.2.1 Investigating Roles of Autocrine and Paracrine Signaling in 3D Stem Cell 
Differentiation 
 







. While the roles of cell-secreted 
signaling are difficult to probe using conventional culture methods, a number of 
microfluidic techniques have been developed for this purpose
98,99,126
. However, these 
studies have focused on 2D cell cultures and not 3D cell aggregate cultures. The 
microfluidic platform developed in Chapters 2 and 3 can be used to modulate cell-
secreted signaling in 3D aggregate cultures by changing media exchange rate and 
frequency. This could be applied in studying how autocrine/paracrine signaling regulate 
specific differentiation events, in a similar approach used by Blagovic et al.
98
 For 
example, Notch-Delta and TGFβ signaling play roles in cell fate decisions during motor 
neuron differentiation
127,142
, but some aspects of this regulation are still not completely 
understood. Operating devices under continuous perfusion could be used to observe 
effects of down-regulating endogenous signaling (ensuring aggregates are small enough 
not to block media exchange through traps). Then, conditioned media and 
supplementation experiments could be used to identify key signaling molecules and their 
roles in cell fate decisions. Overall, experiments such as this could be performed to reveal 
novel mechanisms that regulate stem cell behavior and differentiation. 
5.2.2 Generation of Asymmetrically Patterned Stem Cell Tissues 
 
The platform developed in Chapters 2 and 3 can also be applied in generating 
stem cell tissues with asymmetric patterns of differentiation. In Chapter 3, it was 
demonstrated that, while operating under diffusion-dominated conditions, device features 




applications, including in understanding how symmetry-breaking events occur during 
embryonic development. Examples of approaches currently used to induce spatial 





, or merging multiple pre-patterned cell aggregates
63,88,145
. More 
recently, work has demonstrated that symmetry-breaking events can be generated 




, and gastruloid 
tissues
147
. The technology developed in Chapter 3 offers a complementary approach to 
inducing spatial patterning: the platform can potentially be used to create gradients of 
exogenously delivered molecules or endogenously produced cell signaling molecules, 
depending on if the microfluidic device is operated in a convection- or diffusion-
dominated regime. Overall, this approach can be used to investigate spatial patterning of 
tissues and the roles that different mechanisms play in symmetry breaking during tissue 
morphogenesis. 
5.2.3 Improvements to Brain Organoid Culture Platform 
 
A number of further characterizations and improvements can be made to the 
platform developed in Chapter 4 for culture and assessments of brain organoids. First, 
further characterization of organoid culture in the second generation, flow-through device 
design is still needed. This design incorporated convective media flow through each 
culture chamber to improve delivery of nutrients and removal of waste. Based on 
characterization of organoid gross morphology, size, and growth rate, it is expected that 
the device supports forebrain organoid generation. However, full immunohistological 
characterization is still needed of organoid cell types and structures. This characterization 




Modifications to the way that the organoid platforms are assembled will better 
enable in situ high resolution imaging during culture. Currently, the PDMS devices are 
sealed against a glass slide and clamped with pieces of acrylic. While this allows for low 
magnification and relatively low-resolution imaging, the ultimate goal is to perform 
confocal imaging in the platform. Confocal imaging can be used to perform functional 
calcium imaging of neural activity in organoids as well as to assess cell phenotypes in 
conjunction with tissue clearing and immunocytochemistry. One way to enable confocal 
imaging is to reversibly seal the PDMS devices to coverslip-thickness glass using 
biocompatible adhesive tape. Glass coverslips likely cannot be clamped to the PDMS 
device, as they are more prone to breakage, so adhesive tapes are a possible alternative 
for sealing. If adhesive sealing of glass coverslips is too prone to breakage as well, then 
alternative materials such as cyclic olefin copolymer (COC) films can potentially be used 
as an imaging surface. COC films are optically transparent, particularly in the ultraviolet 
range, and are increasingly used as imaging surfaces in cell biology and microfluidics
148-
150
.   
5.2.4 Drug Screening with Forebrain Organoids 
 
There is much interest in using forebrain organoids to screen potential 
therapeutics for developmental disorders and diseases
54,61
. The platform developed in 
Chapter 4 can be used to address limitations of current organoid culture methods in 
screening. The design of the device is based on a 96 well plate footprint, making it easier 
to incorporate with existing workflows and laboratory equipment. The design can also be 
configured to screen different numbers of independent conditions, with replicates for 




libraries of drug candidates for effects on organoid disease phenotypes, using organoid 
structures and cell types as metrics for assessment. For screening assays in the short term, 
organoid phenotypes can be assessed by end point based assays such as tissue clearing 
with immunocytochemistry. However, in the longer term, it would be valuable to develop 
methods for assessing phenotypes in live organoids—for example, using organoid 
morphological features from bright field images. Ultimately, the organoid culture 
platform can serve as a novel tool for identifying and screening new therapeutics for 










These figures are adapted from a research article entitled ―A microfluidic trap 
array for longitudinal and multi-modal phenotypic analysis of individual stem cell 




Appendix A.1. Stitched representative image of a device loaded with 1000 cell 





Appendix A.2. Additional viability data. Representative confocal images of day 4 
aggregates treated with a LIVE/DEAD stain (live cells: green; dead cells: red). For each 
condition, the top image is a maximum intensity projection of all z slices imaged for a 
given aggregate. Underneath, three z slices are shown. a) Images for both 1000 cell 
starting size aggregates cultured at 10 μL/hr and for 500 cell starting size aggregates 
cultured at 5 μL/hr. b) Images for 100 cell starting size and 500 cell starting size 








Appendix A.3. a) Device culture reduces variability in size for 500 cell starting size 
aggregates. Aggregate radii were quantified from phase contrast images at day 1 and day 
4 of differentiation for 500 cell aggregates cultured under 10 µL/hr media perfusion).  
Two independent samples are shown for each condition, with n ≥ 100 for batch samples 
and n ≥ 85 for device samples. * P < 0.01; *** P < 0.0001. b) Size distributions of 
aggregates captured in devices are similar to batch aggregates. Two replicates per 
condition are shown for 1000 cell aggregates (device culture: 10 µL/hr media perfusion). 
** P < 0.001; *** P < 0.0001  c) Schematic of trap numbering convention used in c and 
d. c,d) Aggregate radii is plotted as a function of position within the device, for 1000 cell 







Appendix A.4. Image processing pipeline used to analyze fluorescent images modified 














Appendix A.5. a) Schematic of trap numbering convention used in b. b) Mean aggregate 
Oct4 expression is plotted as a function of position within the device. One device is 
shown. Performing linear regression on this data produced a line of slope -0.002 and an 
R
2
 value of 0.141, indicating no trend between Oct4 expression and position. c,d) Mean 
aggregate Oct4 expression is plotted as a function of aggregate radius at day 1 (c) and day 
4 (d). e) Scatter plot shows mean Oct4 expression for individual aggregates cultured 
within batch, multiwell, or device platforms (raw data corresponding to Figure 5b). Two 
independent experiments are shown for batch and device conditions (n ≥ 25 each) and 
one experiment is shown for multiwell condition (n = 8). * P < 0.00001 vs. both batch 
and multiwell samples, P < 0.0001 vs. other device sample.   f) Intra-aggregate 
heterogeneity in Oct4 expression for device and batch platforms. Two independent 
experiments are shown for batch and device conditions (n ≥ 25 each). # P < 0.001, $ P < 















Appendix B.1. Histograms show horizontal position of Olig2+ cells with respect to aggregate 
center line for discontinuous perfusion (f = 1 d-1) with 2 μM RA and 1.5 μM Pur. Zero indicates 
aggregate center line, positive numbers indicate portion of aggregate closer to trap entrance, and 






Appendix B.2. Histograms show horizontal position of Olig2+ cells with respect to trap 
coordinates for discontinuous perfusion (f = 1 d
-1
) with 2 μM RA and 1.5 μM Pur. Zero indicates 









Appendix B.3. Histograms show horizontal position of Olig2+ cells with respect to aggregate 
center line for discontinuous perfusion (f = 3 d
-1
) with 6 μM RA and 3 μM Pur, one device. Zero 
indicates aggregate center line, positive numbers indicate portion of aggregate closer to trap 








Appendix B.4. Histograms show horizontal position of Olig2+ cells with respect to aggregate 
center line for discontinuous perfusion (f = 3 d
-1
) with 6 μM RA and 3 μM Pur, a second device. 
Zero indicates aggregate center line, positive numbers indicate portion of aggregate closer to trap 






Appendix B.5. Histograms show horizontal position of Olig2+ cells with respect to trap 
coordinates for discontinuous perfusion (f = 3 d
-1
) with 6 μM RA and 3 μM Pur, one device. Zero 






Appendix B.6. Histograms show horizontal position of Olig2+ cells with respect to trap 
coordinates for discontinuous perfusion (f = 3 d
-1
) with 6 μM RA and 3 μM Pur, a second device. 








Appendix B.7. Histograms show horizontal position of Olig2+ cells with respect to aggregate 
center line for plate controls with 6 μM RA and 3 μM Pur. Zero indicates aggregate center line, 
positive numbers indicate portion of aggregate closer to trap entrance, and negative numbers 






Appendix B.8. Histograms show horizontal position of Olig2+ cells with respect to aggregate 
center line for plate controls with 2 μM RA and 1.5 μM Pur. Zero indicates aggregate center line, 
positive numbers indicate portion of aggregate closer to trap entrance, and negative numbers 












Appendix C.1. Organoid size distributions. Organoid diameter measured at days 14, 21, 
28, and 35 of culture. Diameter was calculated from the cross-sectional area of organoids 
in brightfield images. Each dot represents an individual organoid. Growth rate was 
calculated, defined as the difference in size between two time points and normalized by 






Appendix C.2. Organoid growth rate distributions in device cultures. Growth rate was 
calculated, defined as the difference in size between two time points and normalized by 
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